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Salt-sensitive individuals have blood pressure that is unusually sensitive to salt intake. Because 
salt-sensitivity is a common disorder and may cause high blood pressure, it is a significant public 
health concern. All three epithelial Na+ channel (ENaC) subunits (α, β, and γ) and the 
mineralocorticoid receptor (MR), a known regulator of ENaC, are expressed by vasopressin (VP) 
synthesizing magnocellular neurons in the hypothalamic supraoptic (SON) and paraventricular 
(PVN) nuclei. A growing body of evidence indicates that epithelial Na+ channels (ENaCs) in the 
hypothalamus play a significant role in the development of salt-sensitivity. My dissertation 
research tests the hypothesis that abnormal ENaC regulation occurs in VP neurons during salt-
sensitive hypertension. To investigate this, I first used acute hypothalamic slices in an in vitro 
model to elucidate the ENaC regulatory mechanism present in the VP neurons of normotensive 
rats. Findings from this study demonstrated that aldosterone binds to the MR to directly interact 
with the promoter region of the γENaC gene to increase protein abundance in VP neurons, but 
aldosterone alone does not alter the ENaC-mediated current in VP neurons. To examine ENaC 
regulation during salt-sensitivity, Dahl salt-sensitive (Dahl-SS) and normotensive Sprague- 
Dawley (SD) rats were fed high salt diet to determine if any abnormal responses in the expression 
of ENaC subunits and MR occurred in the hypothalamus and kidney in response to a high dietary 
salt intake. Dietary salt intake caused a significant hypothalamic upregulation of γENaC in salt-
sensitive animals and promoted proteolytic cleavage of the γENaC subunit. In contrast, the same 
dietary regimen caused significant downregulation of hypothalamic MR and kidney αENaC 
expression in normotensive animals. These results indicate a possible compensatory mechanism 
for salt-sensitive hypertension development present at the level of the hypothalamus of 
normotensive animals, which is not observed in salt-sensitive animals. Taken together, findings 
	 x	
from my research suggest that high salt diet initiates a central pathway involving aldosterone-MR-












Salt sensitive hypertension affects 20-30% of the general population (Franco & Oparil, 
2006). Individuals diagnosed with salt-sensitivity experience an abnormal increase in blood 
pressure in response to dietary salt intake. Salt sensitive individuals, regardless of hypertension 
development, are at a higher risk of cardiovascular disease and reduced survival (Weinberger et 
al., 1986; Weinberger et al., 2001). Although the etiology of salt-sensitivity is not well 
understood, a growing body of evidence suggests that abnormal regulation of central epithelial 
sodium channels (ENaC) contributes to the development of this disease state (Gomez-Sanchez & 
Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998). Expression of ENaC has been 
demonstrated in vasopressin and oxytocin synthesizing magnocellular neurons (Teruyama et al., 
2012a) that are present in the hypothalamic supraoptic (SON) and paraventricular nuclei (PVN). 
The studies in chapters 2 and 3 investigate the role of hypothalamic ENaC expression in salt-
sensitive hypertension and the possible mechanism(s) involved in regulating hypothalamic ENaC 
expression in vasopressin- synthesizing neurons.  
Vasopressin 
In response to changes in the blood osmolality, mammals alter their behavior and 
physiology. Changes in thirst and sodium appetite are behavioral responses to aid in the 
regulation of sodium and water balance (Robertson & Athar, 1976; Robertson, 1984; Thompson 
et al., 1986). Additionally, changes in renal excretion of water and sodium are mediated by 
altering plasma concentrations of multiple hormones. An essential hormone involved in this 
process is the antidiuretic hormone, or vasopressin. A member of a hormone superfamily that is 
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expressed in vertebrates and invertebrates (Roch et al., 2011), vasopressin is semi-cyclic 
hormone composed of nine amino acids and is responsible for regulating urine solute 
concentration to maintain  body-fluid homeostasis (Antunes-Rodrigues et al., 2004) and 
cardiovascular control. Additionally, vasopressin been has shown to be is involved in the 
regulation of social behaviors (Ferris, 2005), carbohydrate metabolism (Al-Barazanji et al., 
1998), and thermoregulation (Richmond, 2003).  
Synthesis and release of vasopressin 
Vasopressin is a neurohypophysial hormone synthesized by magnocellular 
neurosecretory cells (MNCs) in the SON and PVN in the hypothalamus (Hara et al., 1990; Ratty 
et al., 1996). The SON is entirely comprised of MNCs, whereas the PVN is divided into a MNCs 
subdivision and a parvocellular subdivision (Swanson & Sawchenko, 1983). Vasopressin is 
transported in the axons of MNCs to the blood capillaries of the posterior pituitary (Bargmann, 
1951) for release into general circulation to mediate a variety of physiological mechanisms (Du 
Vigneaud, 1954). The release of vasopressin is enhanced during times of hyperosmolarity 
(Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975), and hypotension (Khanna et al., 
1994) to produce pressor and antidiuretic effects to counter the physiological changes (Antunes-
Rodrigues et al., 2004). Vasopressin neurons fire in a rhythmic or phasic pattern alternating 
between periods of activity, or “bursts”, followed by a period of inactivity, or “silence” (Dutton 
& Dyball, 1979). Synthesis and release of vasopressin into the general circulation via the 
neurohypophysis is promoted by the physiological demands of maintaining body fluid 
homeostasis (Poulain & Wakerley, 1982). The phasic activity is not coordinated amongst groups 
of vasopressin neurons leading to asynchronous firing and a continuous release of vasopressin 
into circulation rather than a pulsatile release (Leng & Dyball, 1983).  
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Vasopressin receptors 
There are currently three subtypes of vasopressin receptors that have been identified and 
all are seven transmembrane domain, G-protein-coupled receptors that are expressed in a variety 
of tissues. The V1a receptor is expressed in multiple tissue types, including multiple regions of 
the brain, vascular smooth muscle, cardiac myocytes, testes and kidney (Morel et al., 1992; 
Ostrowski et al., 1992; Morel et al., 1993). Activation of the V1a receptor by vasopressin 
binding in the vasculature results in pressor effects, which are primarily detected in the renal and 
hepatic arteries. Unlike the V1a receptor, theV1b receptor has a limited distribution and is most 
abundantly expressed in the anterior pituitary gland where it is involved in the release of 
adrencoticotropin (Tanoue et al., 2004).  Additionally, the V1b receptor is expressed in the 
adrenal glands, kidneys, and pancreas (Sugimoto et al., 1994). The V2 receptor is abundantly 
expressed in the basolateral membrane of principle cells in the renal collecting duct (Lolait et al., 
1992). Binding of vasopressin to the V2 receptor results in the trafficking and insertion of 
aquaporin channels into the luminal membrane of the principle cells to promote water 
reabsorption to affect urine concentration (Birnbaumer et al., 1992; Lolait et al., 1992).  
Role of vasopressin in central autonomic control of blood pressure 
The parvocellular subdivision of the PVN sends projections to the intermediolateral 
column of the spinal cord  (IML) and the rostral ventrolateral medulla (RVLM) to mediate 
sympathetic outflow to the cardiovascular system. In addition to being released from the 
neurohypophysis, vasopressin is also released somato-dendritically by MNCs in the PVN to 
increase the activity of parvocellular neurons that project to the RVLM (Son & Stern, 2011).  
This action, in turn, affects sympathetic outflow and blood pressure (Dampney, 1994). 
Application of VP into the PVN significantly increased sympathetic nervous system activity and 
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blood pressure (Martin et al., 1985), which has been shown to be attenuated with V1a receptor 
antagonists (Rossi & Maliszewska-Scislo, 2008; Lozic et al., 2016). V1a receptors are expressed 
in the IML, a region of the spinal cord that contains the bodies of sympathetic preganglionic 
neurons (Sermasi et al., 1998). This expression pattern further demonstrates the central role that 
vasopressin release has on mediating autonomic control of blood pressure. It should be noted that 
vasopressin released into general circulation does not significantly contribute to mediating blood 
pressure under basal physiological conditions (Hirsch et al., 1993).  
ENaC 
The non-voltage dependent and amiloride-sensitive channel, ENaC is a member of the 
degenerin/epithelial sodium channel (Deg/ENaC) superfamily and is composed of three subunits 
(α, β, and γ) that form a highly selective Na+ channel (Canessa et al., 1994).  ENaC is expressed 
in the apical membrane of epithelia involved in trans-epithelial Na+ transport (Canessa et al., 
1994; Harris et al., 2008), such as in the renal collecting duct, distal colon, and respiratory 
epithelium (Farman et al., 1997; Kellenberger & Schild, 2002). ENaC mediated Na+ transport is 
passive and depends on the electrochemical gradient for Na+ established by the Na+/K+ ATPase 
located on the basolateral membrane (Palmer et al., 1980; DeLong & Civan, 1984; Bens et al., 
1999; Rubera et al., 2003) (See Fig. 1.1).  One of the main roles of functional ENaCs is to aid in 
maintaining salt and water homeostasis at the level of the kidneys where it precisely regulates 
sodium reabsorption to regulate blood pressure and extracellular fluid volume (Rossier, 2014).  
Structure of ENaC  
For ENaC to have full activity, all three subunits must be expressed (Canessa et al., 1994; 
McDonald et al., 1994; Snyder, 2000). The exact stoichiometric of the channel remains 
unknown. However, it is generally accepted that all three of the subunits are involved in the 
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formation of a functional pore (Canessa et al., 1994; Firsov et al., 1998) and several lines of 
evidence suggest a heterotetrameric structure of the channel comprised of 2α, 1β, and 1γ 
subunits (Firsov et al., 1998; Dijkink et al., 2002; Anantharam & Palmer, 2007) or 3α, 3β, and 
3γ subunits (Snyder et al., 1998; Eskandari et al., 1999). 
 
Fig. 1.1. A sketch representation of the movement of Na+ ion in the distal collecting tubule. 
ENaC facilitates the flow of Na+ ions across the luminal membrane into the cytoplasm of 
epithelial cells. The absorbed Na+ ions are then pumped out of the epithelial cell into the 
interstitial space via Na+/K+ ATPase located on the basolateral membrane. Movement of the Na+ 
ions via ENaC has a central role in the regulation of extracellular volume and blood pressure.  


















































ENaC subunits share approximately 30- 40% amino acid sequence homology (Canessa et 
al., 1994) and have similar protein structures with  molecular masses between 70-85 kDa 
(Alvarez de la Rosa et al., 2000; Sun et al., 2011). ENaC subunits are composed of two short 
intracellular N- and C- termini, two transmembrane domains, and a large extracellular loop 
(Canessa et al., 1994; Kashlan et al., 2011; Hanukoglu & Hanukoglu, 2016). In the C-terminus 
of the ENaC subunits there is a highly conserved sequence named the PY (proline- tyrosine) 
motif (See Fig. 1.2). The proline-rich sequence within this motif is a binding site for the 
ubiquitin ligase Nedd4-2 (Neuronal precursor cells expressed developmentally down regulated 
gene 4-2) (Alvarez de la Rosa et al., 2004; Lang et al., 2009; Hallows et al., 2010; Ke et al., 
2010; Chandran et al., 2011), which inhibits ENaC by ubiquitinylating the channel to promote 
internalization from the plasma membrane and eventual degradation (Chen et al., 1999; Lang et 
al., 2009). Interestingly, the αENaC subunit alone expressed as a homomeric channel can 
produce a small, detectable Na+ current that may have a unique physiological role (Canessa et 
al., 1994; Ismailov et al., 1997).  Although the β and γ subunits are not able to produce a 
function channel by themselves, the expression of these subunits significantly impacts the 
specific channel properties including channel kinetics (Fyfe & Canessa, 1998), amiloride 
sensitivity (Fyfe & Canessa, 1998), and ion selectivity (McNicholas & Canessa, 1997).  
ENaC expression in the central nervous system 
ENaC expression in the central nervous has become an area of increasing interest due to 
the expression of the channel in several regions of the brain involved in cardiovascular control 
(Amin et al., 2005). All ENaC subunits are expressed on both the basolateral and apical 
membranes of the choroid plexus and ependymal cells, suggesting ENaC is involved in the 
regulation of sodium concentration in cerebral spinal and brain extracellular fluids (Wang et al., 
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2010). Interestingly, abnormal regulation of sodium in the cerebral spinal fluid contributes to the 
increased sympathetic activity and hypertension development in salt sensitive animal models 





Fig. 1.2. A sketch representation of ENaC structure. ENaC is comprised of three homologous 
subunits (shown in a 2α:1β:1γ ratio). Each subunit consists of two hydrophobic transmembrane 
regions linked by a large, hydrophilic extracellular loop and short, cytoplasmic N-terminus and 
C-terminus regions. The C-terminus contains a PY motif that includes a proline- rich region that 
is important in channel retrieval from the plasma membrane and degradation.  
 
Additionally, several studies demonstrated that central administration of amiloride, or its 
analog benzamil, attenuates sympathetic activity and hypertension in several animal models of 
hypertension (Gomez-Sanchez & Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998; Keep et 
al., 1999; Nishimura et al., 1999; Wang & Leenen, 2002; Wang et al., 2003). 
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ENaC in vasopressin magnocellular neurons 
In the SON and PVN, all three ENaC subunits are specifically expressed in VP-
synthesizing MNCs in the SON and PVN (Teruyama et al., 2012a).  Moreover, these channels 
modulate the membrane potential of the neurons by mediating a Na+ leak current (Teruyama et 
al., 2012a). Because the release of VP is largely regulated by the pattern and frequency of action 
potentials of the synthesizing MNCs (Poulain & Wakerley, 1982), changes in the ENaC-
mediated current in VP MNCs could affect the central and systemic hormonal release. 
Regulation of ENaC 
Proteolytic processing of ENaC is also important for the regulation of ENaC activity and 
surface expression (Rossier, 2004; Kleyman et al., 2006). In particular, proteolytic cleavage of 
the α-and γENaC subunits releases an extracellular inhibitory domain (Passero et al., 2010) is 
critical for full channel activation (Berman et al., 2015; Shobair et al., 2016). Two distinct pools 
are present at the plasma membrane that consists of those that have been cleaved by proteases 
and considered mature subunits or subunits that have not been cleaved and considered immature 
(Hughey et al., 2003; Hughey et al., 2004b). Furin proteases, specifically, act on the extracellular 
domains of the α- and γENaC subunits to produce/modify channel activity (Hughey et al., 
2004a). The physiological importance of proteolytic cleavage of ENaC is still unclear, but it has 
been demonstrated that dietary salt consumption affects protease activity. For example, 
proteolytic cleavage of the γENaC subunit is observed in the kidney during low sodium 
consumption (Masilamani et al., 1999b; Frindt et al., 2008) and has been associated with 
increased channel activity (Frindt et al., 2008). Interestingly, salt deprivation enhances the 
proteolytic cleavage of the γENaC subunit in the kidney collecting tubule (Masilamani et al., 
1999a), suggesting that the cleaved form of the γENaC subunit is required for enhanced ENaC 
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activity in response to physiological demand. However, more mechanistic studies will need to be 
performed to elucidate the relevance of this modification.  
Serum- and glucocorticoid- inducible kinase-1 
Serum- and glucocorticoid- inducible kinase-1 (SGK-1) is a ubiquitously expressed 
enzyme that is considered an important convergence point for multiple regulators of ENaC 
expression and function (Lang et al., 2006; Burton et al., 2009; Lang et al., 2009; Salker et al., 
2011). Aldosterone binds the mineralocorticoid receptor (MR) to increase SGK-1 expression and 
protein abundance (Lang et al., 2009; Fernandes-Rosa et al., 2011). Inactive SGK-1 peptides are 
activated via phosphorylation by 3-phosphoinositide-dependent kinase (PDK1) (Lang et al., 
2009) and mammalian target of rapamycrin mTOR complex-2 (mTORC2), a protein kinase (Lu 
et al., 2010). Activated SGK-1 peptides affect many targets, but importantly SGK-1 
phosphorylates Nedd4-2 to result in inactivation of the ligase. Inactivation of Nedd4-2 by SGK-1 
results in increased ENaC abundance at the cell surface (Debonneville et al., 2001). The 
importance of Nedd4-2 in regulation of ENaC surface expression can be observed in patients 
suffering from Liddle’s syndrome. An autosomal dominant disease, Liddle’s syndrome was first 
described in 1963. Patients exhibited a significantly lower urinary Na+ excretion rate, indicative 
of increased renal reabsorption (Liddle, 1963; Palmer & Alpern, 1998). A point mutation in the 
proline-rich region of the βENaC subunit prevents Nedd4-2 from associating with the channel 
and internalization and proteasomal degradation is prevented (Schild et al., 1996; Butterworth, 
2010; Rotin & Staub, 2011; Hanukoglu & Hanukoglu, 2016). As a result, patients suffer from 
early onset of severe hypertension and have an increased risk of cardiac death (Pagani et al., 
2018). Liddle’s syndrome is a severe disorder that is demonstrates the critical role of ENaC in 
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maintaining a healthy homeostatic state and suggests that other hypertension and cardiovascular 
disorders may involve ENaC misregulation.  
Insulin regulation of ENaC 
Insulin has been demonstrated to stimulate Na+ reabsorption in different portions of the 
kidney including the distal collecting ducts (DeFronzo et al., 1976; Feraille et al., 1995), thick 
ascending limbs (Veelken et al., 1988; Mandon et al., 1993; Ito et al., 1997), and proximal 
tubules (Baum, 1987; Feraille et al., 1992; Feraille et al., 1994). Studies have demonstrated that 
insulin and aldosterone have synergistic anti-natriuretic effects (Miller & Bogdonoff, 1954; 
Fidelman & Watlington, 1984; Johnson et al., 1986) through regulation of ENaC mediated Na+ 
transport (Wang et al., 2001). Acute and chronic infusions of insulin in mice and rats, 
respectively, increased the apical localization of ENaC in the distal collecting duct (Song et al., 
2006; Tiwari et al., 2007). Binding of insulin to the insulin receptor results in allosteric changes 
to promote the recruitment of several adapter proteins that lead to the association of 
phosphatidylinositol 3- kinase (PI3K), which phosphorylates and activate SGK1. Specifically, 
insulin stimulates ENaC by increasing SGK1 activity (Mansley et al., 2016) that results in an 
increased channel open probability (Marunaka et al., 1992) and increased channel density at the 
cell membrane (Blazer-Yost et al., 1998).  
Vasopressin regulation of ENaC 
Mammalian collecting ducts exposed to vasopressin have increased ENaC activity. 
Electrophysiological studies have shown that vasopressin exposure results in increased channel 
open probability and the number of channels in the apical plasma membrane (Bugaj et al., 2009). 
Inhibition of cAMP (cyclic adenosine monophosphate) signaling prevents the vasopressin 
induced increase in ENaC activity, suggesting vasopressin via cAMP signaling promotes 
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trafficking and insertion of ENaC channels into the apical membrane of principle cells of the 
distal collecting duct (Ecelbarger et al., 2000; Ecelbarger et al., 2001; Nicco et al., 2001; Morris 
& Schafer, 2002; Sauter et al., 2006). Vasopressin binds to V2 receptors to initiate a signaling 
cascade to promote the production of cAMP to increase both ENaC and aquaporin 2 activities 
(Birnbaumer et al., 1992; Lolait et al., 1992) that result in increased sodium reabsorption and 
osmotic gradients, as well as increased water permeability in the collecting duct (Canessa & 
Schafer, 1992; Lahr et al., 2000; Morris & Schafer, 2002; Butterworth et al., 2005; Shane et al., 
2006). It should be noted that vasopressin works in a synergistic manner with aldosterone to 
increase ENaC activity (Fig. 1.3). 
 
Fig. 1.3. A sketch representation of the synergistic effects of aldosterone and vasopressin. 
Aldosterone binds to the MR to promote synthesis of ENaC subunits to generate intracellular 
pools. Upon binding of vasopressin to the V2 receptor, pre-existing intracellular pools of ENaC 
subunits ENaC are translocated to the apical membrane to promote Na+ reabsorption.  
 
Animals that are deprived of water and Na+ or treated with both vasopressin and aldosterone 
have the most active form of ENaC (Reif et al., 1986; Schlatter & Schafer, 1987; Bindels et al., 
1988; Chen et al., 1990; Hawk et al., 1996; Bugaj et al., 2009). 































Aldosterone regulation of ENaC 
Within the epithelia, ENaC expression is primarily regulated by the main 
mineralocorticoid, aldosterone, binding to the MR in a tissue specific manner (Renard et al., 
1995; Escoubet et al., 1997; Stokes & Sigmund, 1998a; Masilamani et al., 1999a; MacDonald et 
al., 2000). Activation of ENaC requires expression of its regulatory proteins that are also 
regulated by aldosterone and other factors (Stokes, 1999; Stockand, 2002). In taste receptor cells, 
aldosterone induces γENaC expression (Lin et al., 1999) where these channels play a critical role 
in transducing salt taste (Gilbertson & Kinnamon, 1996; Kinnamon & Margolskee, 1996; 
Lindemann, 1996). Increases in blood aldosterone enhance the intensity of the apical 
immunoreactivity for βENaC and γENaC, and increase the amplitude of amiloride-sensitive 
current in taste cells (Lin et al., 1999) indicating an increased salt appetite in response to 
aldosterone. Aldosterone appears to specifically induce the αENaC subunit in the kidney and 
several studies have documented the effect of aldosterone on ENaC subunit expression in the 
kidney (Renard et al., 1995; Asher et al., 1996; Escoubet et al., 1997; Stokes & Sigmund, 1998b; 
Masilamani et al., 1999a; MacDonald et al., 2000). All of these studies have utilized different 
approaches. Nonetheless, the results consistently show that aldosterone affected gene expression 
of the αENaC subunit, but not γENaC or βENaC subunits in the kidney. For instance, a 
deficiency in dietary NaCl intake, known to increase the circulatory level of aldosterone, caused 
upregulation of αENaC in the kidney (Renard et al., 1995; Stokes & Sigmund, 1998b; 
Masilamani et al., 1999a). Adrenalectomy caused a decrease in αENaC expression, while 
treatment with aldosterone restored the expression (Escoubet et al., 1997; MacDonald et al., 
2000). In addition to studying the effects on kidney ENaC expression, several studies have 
investigated the effects of aldosterone on colon ENaC expression. Although aldosterone 
	 13	
upregulated αENaC expression at the level of the kidneys, the γENaC expression was increased 
in the colon in these animals (Asher et al., 1996; Escoubet et al., 1997; Stokes & Sigmund, 
1998b). Collectively, these studies reveal that aldosterone selectively influences specific ENaC 
subunit expression in a cell type and/or tissue-specific manner.  
Renin-angiotensin-aldosterone system 
Aldosterone was first characterized in the early 1950s due to its mineralocorticoid effects 
on urinary Na+/K+ ratios (Simpson et al., 1954). Synthesized from cholesterol within the zona 
glomerulosa of the adrenal glands, aldosterone is released into circulation in response to changes 
in blood pressure through the renin-angiotensin II-aldosterone system (RAAS), which works at 
the level of the kidney to regulate sodium and water balance (Nishiyama & Kim-Mitsuyama, 
2010). A decrease in blood pressure is first noted in the afferent arterioles of the kidney as a 
decrease in renal perfusion that causes mechanoreceptors to release prorenin that is converted to 
renin by the juxtaglomerular cells of the kidney (Sealey et al., 1977; Hackenthal et al., 1990; 
Hall, 2001; Persson et al., 2004). Renin cleaves the liver-synthesized and secreted hormone 
angiotensinogen to angiotensin I (Menard et al., 1983; Deschepper, 1994; Hall, 2001), which is 
subsequently hydrolyzed to angiotensin II by angiotensin- converting enzyme (ACE) located in 
the pulmonary and renal endothelium (Ng & Vane, 1967; Wei et al., 1991; Soubrier et al., 
1993a; Soubrier et al., 1993b; Corvol et al., 1995; Costerousse et al., 1998; Hall, 2001). 
Angiotensin II binds angiotensin II type 1 and 2 receptors to have effects on the kidney, adrenal 
cortex, arterial, and brain (Nishiyama et al., 2009). In the kidney, angiotensin II increases Na+/H+ 
exchange to promote sodium reabsorption to raise blood osmolality (Xu et al., 2006; Li & Zhuo, 
2007), which results in increased blood and extracellular fluid volume and an overall increase in 
arterial pressure. Angiotensin II induces vasoconstriction by binding to receptors located on 
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vascular smooth muscle cells or inducing the zona glomerulosa of the adrenal cortex to stimulate 
the systemic release of aldosterone (Hollenberg & Williams, 1979; Quinn & Williams, 1988; 
Hall, 2001). Subsequently, aldosterone via the mineralocorticoid receptor (MR) increases sodium 
reabsorption and potassium excretion at the distal tubule and collecting duct of the kidney 
nephron to affect blood osmolarity by increasing expression of ENaC (Davis, 1957; Stokes & 
Sigmund, 1998a; Masilamani et al., 1999b; Fuller & Young, 2005; Frindt et al., 2008; Scott & 
Dunn, 2017) and Na+/K+ ATPase (Derfoul et al., 1998; Gensini et al., 2002; Chaszczewska-
Markowska et al., 2016) in the cell membrane of principle cells located in the distal tubule and 
collecting ducts.  
Aldosterone in the central nervous system   
Unlike most steroids, circulating aldosterone has difficulty crossing the blood-brain 
barrier (BBB) (Pardridge & Mietus, 1979a, b; Pardridge, 1981; Funder & Myles, 1996; Parker et 
al., 2006). It is known, however, that a small amount of aldosterone is synthesized in the brain 
independently of the adrenal cortex. The transcripts of aldosterone synthase (CYP11B2), an 
enzyme that converts 11-deoxycorticosterone to aldosterone, has been detected in several brain 
regions including the rat hypothalamus (MacKenzie et al., 2000). The capability of the brain 
tissue to synthesize aldosterone was also demonstrated in vitro (Gomez-Sanchez et al., 2005a). 
Moreover, a recent study used in situ hybridization to detect the presence of aldosterone synthase 
in magnocellular neurons in the SON (Wang et al., 2016).  
Aldosterone regulation of ENaC in the central nervous system  
Several studies suggest the ENaCs in the brain are also regulated by aldosterone. 
Administration of aldosterone in the rat brain increases blood pressure (Gomez-Sanchez et al., 
1992; Wang & Leenen, 2002; Wang et al., 2003). Importantly, this effect was attenuated by 
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central administration of the ENaC inhibitor, benzamil (Gomez-Sanchez & Gomez-Sanchez, 
1995; Nishimura et al., 1998), suggesting that aldosterone-regulated benzamil-sensitive 
structure(s) in the brain are involved in the regulation of blood pressure. Intracerebroventricular  
(ICV) infusion of the aldosterone synthase inhibitor, FAD286, prevented the increase in both 
hypothalamic aldosterone and blood pressure associated with high dietary salt intake in Dahl salt 
sensitive rats (Huang et al., 2008). Chronic subcutaneous aldosterone infusion for 10 days was 
found to increase γENaC mRNA level in the subfornical organ (SFO) of the hypothalamus in rats 
that were provided with saline drinking fluid (aldosterone salt-induced hypertension model) 
(Wang et al., 2016). Although the SFO is a structure in the brain, it is known that it lacks the 
BBB and shows high expression of MR (Amin et al., 2005). Therefore, aldosterone from 
subcutaneous infusion may directly affect the expression of γENaC in the SFO. Although several 
lines of evidence suggest that aldosterone is synthesized locally in the hypothalamus by MNCs 
(Wang et al., 2016), the physiological conditions and mechanisms that induce aldosterone 
synthesis in the hypothalamus are still largely unknown. 
Glucocorticoid regulation of ENaC 
Glucocorticoid induction of ENaC subunit expression is well documented in different cell 
types and organs. Glucocorticoid, but not aldosterone, was found to induce the expression of all 
ENaC subunits (Champigny et al., 1994; Renard et al., 1995). Subcutaneous infusion of either 
aldosterone or the glucocorticoid receptor (GR) agonist, dexamethasone, for three days induced 
αENaC expression in the kidney, whereas this treatment resulted in the induction of βENaC and 
γENaC expression in the distal colon of the same animals (Asher et al., 1996). In addition, 
studies have shown that the functional properties of the glucocorticoid-MR complexes are 
different from those of aldosterone-MR complexes (Lombes et al., 1994; Kitagawa et al., 2002). 
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Glucocorticoids and mineralocorticoids have different effects on ENaC activity in the kidney 
(Frindt & Palmer, 2012). Infusion of the synthetic glucocorticoid, dexamethasone, resulted in an 
increase in the abundance of αENaC in the rat kidney. However, this response was not 
accompanied by an induction of amiloride-sensitive Na+ currents, an increase in the abundance 
of the cleaved (active) forms of either αENaC or γENaC, or the expression of βENaC or γENaC 
protein at the cell surface (Frindt & Palmer, 2012). It is possible that the GR- corticosterone 
complex does not affect expression of some of the ENaC regulatory proteins to induce full 
channel activation. Further experiments are needed to clearly define the specific pathway 
involving glucocorticoid regulation of ENaC and how it differs from mineralocorticoid 
regulation.  
Mineralocorticoid and glucocorticoid receptors  
Both the MR and GR belong to the nuclear receptor superfamily and act as ligand-
induced transcription factors to regulate gene expression (Vallon et al., 2005; Ronzaud et al., 
2007; Ackermann et al., 2010). MR has three known ligands: aldosterone, cortisol, and 
progesterone (Myles & Funder, 1996; Quinkler et al., 2004). Additionally, corticosterone binds 
to the GR and MR with similar affinity (Beaumont & Fanestil, 1983; Krozowski & Funder, 
1983; Reul & de Kloet, 1985; Sheppard & Funder, 1987a; Sheppard & Funder, 1987b; Funder, 
1995). Upon hormone binding in the cytosol, MR forms homodimers and heterodimers with GR 
and is translocated into the nucleus where it binds to the hormone-responsive element of the 
target gene (Ou et al., 2001; Gekle et al., 2014). Since the DNA binding domains of the MR and 
GR share approximately 94% amino acid homology (Viengchareun et al., 2007), both the MR 
and GR are thought to bind common hormone-responsive elements in a sequence-specific 
manner to regulate some of the same genes (Evans & Arriza, 1989). It is known that activation of 
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MR requires coactivators and some of the MR coactivators appear to be ligand-specific, such as 
the coactivation of the MR that occurs in the presence of aldosterone, but not of cortisol 
(Kitagawa et al., 2002). 
11β-hydryoxysteriod dehydrogenase type 2  
Although the plasma concentrations of glucocorticoids are substantially higher than those 
of aldosterone (Holbrook et al., 1980), aldosterone is known to preferentially bind to MR in 
aldosterone sensitive-epithelia (Odermatt et al., 2001). Aldosterone selectivity of the MR in the 
epithelia is achieved by inactivating intracellular glucocorticoids through the glucocorticoid-
inactivating enzyme, 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2) (Gomez-Sanchez et 
al., 2005b), which converts corticosterone into inactive metabolites (Funder, 1995; Naray-Fejes-
Toth et al., 1998). Experiments with HEK-293 cultured cells expressing recombinant MR and 
11β-HSD2 showed that11β-HSD2 is associated with the MR at the endoplasmic reticulum 
membrane and prevents cortisol activation of MR (Odermatt et al., 2001).  
Rationale for the current studies 
Previous studies have investigated the role of the ENaC in vasopressin-synthesizing 
neurons and found that ENaC contributes to the resting membrane potential in these neurons 
(Teruyama et al., 2012b). Additionally, it was previously demonstrated that normotensive 
animals fed high salt diet had an increase in γENaC expression and associated enhanced ENaC 
activity in VP neurons (Sharma et al., 2017). The regulatory mechanism of ENaC expression in 
these neurons remains unknown. Studies conducted in Chapter 2 sought to elucidate the 
regulatory mechanism involved in vasopressin-synthesizing neurons with regard to ENaC 
expression. Overall, results from this study demonstrated aldosterone-binding to the MR results 
in increased γENaC expression and abundance. It was also previously shown that Dahl-SS rats, 
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an established animal model of salt–sensitivity, have elevated central aldosterone synthesis 
(Gomez-Sanchez & Gomez-Sanchez, 1995) and elevated aldosterone levels contributes to salt-
sensitive hypertension development (Huang et al., 2009; Gomez-Sanchez et al., 2010). However, 
the effect of high dietary salt intake on central ENaC expression has not been examined during 
times of salt-sensitivity. Studies conducted in Chapter 3 sought to determine the effect of dietary 
salt on hypothalamic and kidney ENaC expression in Dahl-SS rats and normotensive Sprague-
Dawley rats. Results from this study suggest that animals with salt-sensitivity lack a 
compensatory mechanism that is present in normotensive animals to prevent hypertension 
development.  
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ALDOSTERONE MEDIATED REGULATION OF EPITHELIAL SODIUM 
CHANNEL (ENAC) IN THE RAT HYPOTHALAMUS  
 
Introduction 
Vasopressin (VP) is synthesized in magnocellular neurons located in both the 
paraventricular (PVN) and the supraoptic (SON) nuclei of the hypothalamus and is released from 
the neurohypophysis into the general circulation. VP neurons increase VP secretion in response 
to hyperosmolality (Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975) and hypotension 
(Khanna et al., 1994) to produce antidiuretic and pressor effects. The release of VP also occurs 
from the soma and dendrites of VP neurons in the PVN to increase the activity of parvocellular 
neurons within the PVN that project to the rostral ventrolateral medulla (Son & Stern, 2011). 
This action affects sympathetic outflow and blood pressure (Dampney, 1994). VP neurons thus 
play a pivotal role in coordinating neuroendocrine and autonomic responses to maintain 
cardiovascular homeostasis. Because the release of VP depends largely on the pattern of 
neuronal activity of the synthesizing neurons (Poulain & Wakerley, 1982; Cazalis et al., 1985), 
factors modulating neuronal activity of VP neurons are of great interest.  
 The non-voltage dependent and amiloride-sensitive epithelial Na+ channel (ENaC) is a 
member of the degenerin/epithelial sodium channel (Deg/ENaC) superfamily and is composed of 
three subunits (α, β, and γ) that form a highly selective Na+ channel (Canessa et al., 1994). 
ENaC is present in aldosterone-sensitive epithelia that are responsible for trans-epithelial Na+ 
transport, such as in epithelial cells that line the distal part of the renal tubule, the distal colon, 
the duct of several exocrine glands, and the lung. ENaC expression was also demonstrated in 
various structures in the brain, namely the SON, PVN, subfornical organ, choroid plexus, and 
ependyma of the anterovental third ventricle (Amin et al., 2005). Although the functions of 
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ENaC in the brain are still largely unknown, several studies showed that central administration of 
the ENaC blocker, amiloride or its analog benzamil, attenuates sympathetic activity and 
hypertension in several animal models of hypertension (Gomez-Sanchez & Gomez-Sanchez, 
1994, 1995; Nishimura et al., 1998; Keep et al., 1999; Nishimura et al., 1999; Wang & Leenen, 
2002; Wang et al., 2003) and heart-failure (Ito et al., 2015), indicating that abnormally regulated 
ENaC in the brain plays a significant role in the development of hypertension. 
 Our previous study (Teruyama et al., 2012b) demonstrated that ENaC is specifically 
expressed in VP neurons and modulates the membrane potential by mediating a Na+ leak current. 
In addition, our recent study showed that animals that consumed high dietary salt displayed an 
enhanced ENaC current, which resulted in further depolarization of the basal membrane potential 
of VP neurons (Sharma et al., 2017). These findings indicate that high dietary salt intake 
enhances the expression and activity of ENaC, which in turn, augments synaptic drive during 
hormonal demand by depolarizing the basal membrane potential closer to the action potential 
threshold. Activation of ENaC, therefore, is a powerful means to modulate hormone secretion 
according to physiological demands. Furthermore, considering the role of VP in the 
cardiovascular homeostasis, ENaC in VP neurons may have a major role in the regulation of 
blood pressure. However, the mechanism underlying the regulation of ENaC activity in VP 
neurons remains mostly unknown. 
 ENaC expression in epithelia is primarily regulated by the mineralocorticoid, aldosterone, 
via the mineralocorticoid receptor (MR) (Renard et al., 1995; Escoubet et al., 1997; Stokes & 
Sigmund, 1998a; Masilamani et al., 1999; MacDonald et al., 2000). Because the MR and ENaC 
are co-localized in VP neurons in the SON and PVN (Teruyama et al., 2012a; Haque et al., 
2015), ENaC in VP neurons are likely regulated by aldosterone. The present study using acutely 
	 37	
prepared hypothalamic slices incubated with aldosterone was conducted to examine the effects of 
aldosterone on the expression and activity of ENaC in VP neurons. This in vitro approach 
allowed us to evaluate the effect of aldosterone on ENaC in VP neurons more directly without 
the context of whole animal physiology.  
Methods 
Animals 
Male Wistar rats (Harlan Laboratories, Indianapolis, IN) weighing between 260-300g 
were used in the present investigation.  Rats were housed on a 12:12-h light-dark cycle and were 
allowed standard chow and water ad libitum. All	protocols	were	carried	out	in	accordance	
with	the	National	Institute	of	health	Guide	for	the	Care	and	Use	of	Laboratory	animals	and 
were approved by the Institutional Animal Care and Use Committees of Louisiana State 
University.  
Acute hypothalamic slice preparation 
Rats were deeply anaesthetized with Ketamine-Xylazine (9:1, 100 mg/kg i.p.) and 
perfused through the heart with cold artificial cerebral spinal fluid (aCSF), in which NaCl was 
replaced by equiosmolar sucrose containing (in mM: 210 Sucrose, 3 KCl, 2.0 CaCl2, 1.3 MgCl2, 
1.24 NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4). The brain of each rat 
was removed and three coronal slices (500 µm), containing the entirety of the SON and PVN, 
were collected using a vibrating microtome (Leica VT1200; Leica, Mannheim, Germany). Other 
brain areas that are known to express ENaC, namely the vascular organ of lamina terminalis 
(OVLT)	(Miller & Loewy, 2013), area postrema (Miller et al., 2013), and subfornical organ 
(SFO) (Wang et al., 2016), were not included. Slices were divided into two equal halves along 
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the midline at the third ventricle using microdissection scissors. Slice halves from the right side 
were placed in the control group, while the left halves were placed in the treatment group.   
In vitro incubation with corticosteroids 
The hypothalamic slices were incubated on a plastic tray that consisted of wells with 
nylon mesh bottoms to hold individual slices in a glass beaker that was filled with 200 ml 
artificial cerebral spinal fluid (aCSF) (in mM: 125 NaCl, 3 KCl, 2.0 CaCl2, 1.3 MgCl2, 
1.24 NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4) with normal 
physiological osmolality (~295 mOsm/kg). The normal physiological osmolality of aCSF was 
chosen to avoid possible effects of higher osmolality on ENaC expression, since 
intracerebroventricular (ICV) infusion of Na+-rich aCSF caused an increase in hypothalamic 
aldosterone concentration in rats (Huang et al., 2008) and vasopressin neurons are directly 
osmosensitive (Oliet & Bourque, 1993). The slices were continuously oxygenated with 95% O2/ 
5% CO2 gas and maintained at 34°C. The incubation trays were placed at approximately half the 
depth of the beaker to ensure that the slices were completely immersed throughout the 
experiment. Slices were incubated for 6 hr with aldosterone, corticosterone, or vehicle. An 
incubation time of 6 hr was chosen because a pilot study showed 6 hr is the minimum duration 
that produced significant changes in the amount of γENaC mRNA. In addition, a longer 
incubation time did not allow us to conduct several-hour-long electrophysiological experiments 
before the brain slices started to deteriorate. In some experiments, slices were preincubated for 
30 min with the antagonist for the MR or glucocorticoid receptor (GR) to block MR and GR 
prior to aldosterone or corticosterone application, respectively. Following incubation, slices were 
trimmed along the dorsal portion of the third ventricle lateral to the optic chiasm to minimize 
tissue that did not contain the PVN and SON and to exclude the choroid plexus that is known to 
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express ENaC subunits (Amin et al., 2005). Trimmed slices were placed in RNALater (Qiagen,	
Germantown, MD) and stored at -20°C for later processing. Additional hypothalamic slices were 
fixed in 4% paraformaldehyde with 0.1% picric acid in 0.15 M sodium phosphate buffer (pH 7.2-
7.4) and processed for immunocytochemistry. 
Corticosteroids and antagonists 
Aldosterone and corticosterone were purchased from Sigma-Aldrich (St. Louis, MO). 
Antagonists for MR and glucocorticoid receptors (GR) were RU-28318 (Tocris Bioscience, 
Ellisville, MO) and RU-486 (Sigma- Aldrich, St. Louis, MO), respectively. All compounds were 
dissolved into dimethyl sulfoxide (DMSO) to make stock solutions and were further diluted in 
aCSF to reach the final concentration. The concentration of aldosterone, corticosterone, and RU-
28318 used for incubations was 2.5 µM and RU-486 was 5 µM. The final concentration of 
DMSO in aCSF was 0.05% when aldosterone or corticosterone was applied and 0.1% when MR 
or GR antagonists were applied in addition to aldosterone or corticosterone.   
Real-time PCR 
Total RNA was isolated using TriReagent (Sigma-Aldrich, St Louis, MO) according to 
the manufacture’s instructions, and tissue was homogenized using a tissue lyser (Qiagen, 
Valencia, CA). Lysate was then treated with chloroform (ThermoFisher Scientific, Waltham, 
MA) and centrifuged at 12,000 rpm for 15 min. Total RNA was precipitated from the aqueous 
stage using isopropyl alcohol, and then washed with ethanol. Precipitate was suspended in 20 µl 
RNAase-free water. The concentration and quality of the isolated RNA were assessed using a 
spectrophotometer (NanoDrop 1000, ThermoFisher Scientific, Waltham, MA). Isolated mRNA 
was reverse transcribed to cDNA using oligo dT and M-MLV reverse transcriptase (Sigma-
Aldrich, St. Luis, MO) and used in real-time RT-PCR analysis.  The ABI ViiA-7 sequence 
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detection system (ABI Applied Biosystem, Grand Island, NY) was used in conjunction with the 
SYBR Select Master Mix (ABI Applied Biosystem, Grand Island, NY). All samples were 
measured in triplicate and the two closest cycle threshold (Ct) values were averaged for each 
sample.   
 The effects of the treatments were examined via the relative changes of the specific target 
genes, which were calculated using the comparative cycle threshold method. For each sample, 
the average Ct value of the target gene was subtracted by the housekeeping (Cyclophilin B) gene 
to obtain the ΔCt value. The ΔCt values of the designated control group were averaged and 
subtracted from each sample to generate the ΔΔCt value. Relative change was then calculated for 
each sample by using the formula 2 - Δ ΔCt. All results are shown as relative change in comparison 
to the control. The Student's t test was used for comparison between treatment groups. 
Differences were considered to be statistically significant at p <0.05. 
Primers of selected genes were designed using Primer 3 software (Whitehead Institute for 
Biomedical Research) and purchased from Sigma-Aldrich (St. Louis, MO). All primer sequences 
were blasted on the National Center for Biotechnology Information database to determine 
specificity of targeted gene. The sequences of the primer used are listed in Table 1.  
Semiquantitative immunoblotting 
Total protein lysate samples were collected from above mentioned hypothalamic slice 
preparation. The hypothalamic slices were incubated for 6 hr with 2.5 µM aldosterone or vehicle, 
and were rinsed with cold PBS and placed in microcentrifuge tubes containing 250 µl of chilled 
complete lysis buffer. Lysis buffer was made fresh before each experiment. Complete buffer 
contained: RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 
0.1% SDS, 50 mM Tris, pH 8.0; Sigma-Aldrich, St. Louis, MO), protease inhibitors 
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(ProteoGuardTM EDTA-free protease inhibitor cocktail; Takara Clontech, Mountain View, CA), 
1 mM EGTA, 1 mM EDTA, and 1mM DTT.  Samples were briefly homogenized utilizing an 
electric tissue lyser (Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed 
samples were centrifuged for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the 
clear supernatant (total lysate) was transferred to a clean tube to be stored at -20°C for later 
processing. 
 After protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford, 
Illinois, USA), samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer 
(Bio-Rad) for 5 min at 95°C. Samples were resolved in a 4-15% SDS-PAGE (Mini PROTEAN 
Precast Gels, Bio-Rad) gradient gel in Tris-glycine buffer (25 mM, 192 mM glycine, 0.1% SDS, 
pH 8.3; Bio-Rad) and transferred to a PVDF membrane (Bio-Rad, Hercules, CA) under wet 
conditions (50V for 2 hr at 4°C). To determine a successful transfer, the membrane was stained 
with Ponceau S solution (Sigm-Aldrich, St. Louis, MO) for approximately 1 min. The membrane 
was destained with 0.1 M NaOH for 30 sec followed by quick TBST wash (TBS-Tween; 50 mM 
Tris base, 200 mM NaCl, 0.05% Tween 20). The membrane was blocked with 5% non-fat buffer 
(NFM; Bio-Rad, Hercules, CA) for 1 hr at room temp, and incubated overnight at 4°C with the 
selected primary antibody dissolved in 5% NFM buffer. A final concentration for all ENaC 
primary antibodies was 1 µg/ml. Glyceraldehydye 3- phosphate dehydrogenase (GAPDH; 
Abcam, Cambridge, MA) primary antibody was used as a load control with a final concentration 
of 0.125 µg/ml. The next day, the membrane was washed three times for 10 min each with TBST 
and incubated with the horseradish peroxidase- conjugated (HRP) secondary antibody against the 
respective host species (1:10,000, Goat- anti Rabbit – HRP; 1:10;000, Goat- anti Mouse, Bio-
Rad) dissolved in 5% NFM buffer at room temp for 2 hr followed by six TBST washes for 10 
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min each. Protein bands were detected through chemiluminescence reagents (ClarityTM Western 
ECl Substrate Kit; Bio-Rad, Hercules, CA) and imaged utilizing a gel imaging system 
(ChemiDocTM XRS+; Bio-Rad, Hercules, CA). Densitometric measurements were obtained 
through ImageJ (NIH, Bethesda, MD).  
Chromatin Immunoprecipitation (ChIP) and qPCR analyses 
The rats (n=19) were deeply anesthetized with Ketamine:Xylazine (9:1; 100 mg/kg; i.p.) 
and transcardially perfused with an artificial cerebrospinal fluid (aCSF) in which NaCl was 
replaced by equiosmolar sucrose  (in mM: 210 Sucrose, 3 KCl, 2 CaCl2, 1.3 MgCl2, 1.24 
NaH2PO4, 25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose; pH 7.4). The brains were removed 
and a hypothalamic block (4.5mm: 0.4gm) containing the SON and PVN was made. Kidneys 
were also removed and blocked to be of equal weight as the brain. The blocked tissues were 
ground and homogenized in 2 ml sodium phosphate buffered saline (PBS; pH 7.2) containing 20 
µl protease inhibitor (635673, Clontech, Mountain View, CA). The homogenized samples were 
first cross-linked with 1% formaldehyde for 20 min at 37 ºC, and then lysed in SDS lysis buffer 
(1% SDS, 10mM EDTA, 50mM Tris-HCl; pH 8.1) containing a protease inhibitor. The released 
nuclei were fractioned with sonication to obtain a pool of DNA fragments of 300 to 500 bp in 
length. The sonicated samples were divided into 3 individual aliquots. 60 µl of the protein A/G 
plus agarose beads (sc-2003, Santa Cruz Biotechnology, Dallas, TX) were added to two tubes 
and incubated for 2 hr at 4 ºC with gentle agitation to preclear the lysates. One tube containing 
the lysate was used as the input control. The samples were centrifuged at 2,000 rpm at 4 ºC for 5 
min, and one of the two subsequent supernatants was used for immunoprecipitation. Four 
different anti-MR monoclonal antibodies (rMR1-18 1D5, MRN2 2B7, MRN3 3F10, and 
rMR365 4D6) were obtained from the Developmental Studies Hybridoma Bank (Iowa City, IA). 
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The supernatants were incubated with a cocktail of the anti-MR antibodies at equal ratio (2.5 µg) 
for overnight at 4 ºC with gentle agitation. After incubation with the antibodies, 120 µl of the 
protein A/G agarose beads were added to both tubes (with Ab and without Ab) and incubated 
overnight at 4 ºC. Subsequently, the samples were centrifuged at 1,000 rpm at 4 ºC for 5 min to 
remove the supernatants and the remaining beads were washed five times in wash buffers. The 
proteins were eluted using an elution buffer containing 1% SDS and 0.1M NaHCO3. The protein-
DNA crosslinks were reversed by heating at 65 ºC overnight with gentle agitation. The DNA was 
recovered by phenol/chloroform extraction, precipitated with ethanol, and dissolved in 25 µl TE 
buffer (pH 8.0). Input control, Ab, and no Ab samples (2 µl each) were subjected to PCR with 
JumpStart REDTaq DNA polymerase (D0563, Sigma- Aldrich, St. Louis, MO) to detect the MR-
binding sites in the promoter region in Scnn1g. The primer set (Forward 5’- 
GAAGGGTGAGATGGATTGGA- 3’ and Reverse 5’- GTAGGGGAAAGGGGGTAACA- 3’, 
chr1:191706400-191706675, 276 bp) was specifically designed based on a previous study 
(Lombès et al., 1993). The following PCR conditions were used: 95 ºC for 90 sec, 45 repetitions 
of the following cycles 95 ºC for 30 sec, 60 ºC for 10 sec, 72 ºC for 60 sec, and final extension at 
72 ºC for 5 min. The PCR products from the input DNA, negative control (no Ab) and MR ChIP 
were separated by agarose gel electrophoresis and visualized with ethidium bromide. For 
quantitative PCR (qPCR) analysis, the total DNA concentrations of the samples were measured 
using Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA) and normalized so that equal 
amounts of DNA were amplified. The normalized product (2 µl) was used for PCR with SYBR 
Select Master Mix (4472897, ABI Applied Biosystems, Foster City, CA). The following PCR 
conditions were used: 95 ͦ C for 90 sec, 40 repetitions of the following cycles 95 ͦ C for 30 sec, 
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60 ͦ C for 60 sec, and final extension at 72 ͦ C for 5 min. Results are reported as a percent change 
compared to the input control. 
Immunocytochemistry 
Hypothalamic slices from six animals were processed concurrently under the same 
conditions for immunocytochemical localization of ENaC subunits. The 500 µm thick 
hypothalamic slices were cryoprotected by immersing in 50% glycerol in PBS for ~5 min before 
mounting on a freezing microtome (SM2010R; Leica, Mannheim, Germany) and sectioned at 40 
µm. Slices were incubated with 5% normal goat serum in PBS containing 0.5% Triton X-100 
(PBST) for 30 min at room temperature followed by the primary antibodies directed against 
αENaC, βENaC, or γENaC at dilutions of 1:2,000, 1:500, and 1:4,000, respectively at 4°C with 
continuous gentle agitation for overnight. The rabbit antibodies against the ENaC subunits were 
a generous gift from Dr. Mark A. Knepper (National Institutes of Health, Bethesda, MD), and the 
characterizations of these antibodies were previously described in great detail (Masilamani et al., 
1999). The hypothalamic slices were incubated with biotinylated goat-anti-rabbit IgG (1:500 in 
PBST; Vector, Burlingame, CA) for 2 hr and with ABC complex (1:500 in PBST, Vector, 
Burlingame, CA) for 1 hr. Subsequently, slices were incubated with diaminobenzidine (DAB; 
Vector, Burlingame, CA) to visualize the immunoreactivity. Slices were washed in PBST (3x5 
min each) between each step. Finally, slices were mounted on subbed slides, air-dried overnight, 
dehydrated in a series of alcohols, cleared in xylene, and coverslipped with Permount (Fisher 
Scientific, Waltham, MA) mounting medium. The hypothalamic slices containing the SON and 
PVN were digitally photomicrographed in 12-bit intensity levels using a microscope (Nikon 
Eclipse 80i, Tokyo, Japan) equipped with a digital camera (Nikon DS-QiMc, Tokyo, Japan). 
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 For fluorescent confocal microscopy, the brain slices were incubated with a secondary 
antibody (goat anti-rabbit) conjugated with DyLight 594 (Jackson ImmunoResearch, West 
Grove, PA) for 4 hr at room temperature. The hypothalamic slices were examined with a 
confocal microscope (Leica TCS SP8, Mannheim, Germany) using a 63X/1.4 n.a. oil immersion 
objective lens. Confocal z-stacks (1024x1024; 0.232 µm/pixel) were acquired at the optical 
section thickness of 1 µm. 
Electrophysiology 
Brain slices were obtained as described in Acute hypothalamic slice preparation and 
incubated with aldosterone or vehicle for 6 hr prior to the electrophysiological experiments. 
Whole-cell currents were recorded digitally at 20 kHz and filtered at 5 kHz with a Digidata 
1440A and an Axopatch 700B (Molecular Devices, Foster City, CA) amplifier in conjunction 
with PClamp 10 software (Molecular Devices, Foster City, CA). Magnocellular neurons in the 
SON were visually identified with a microscope (Olympus BX50WI, Tokyo, Japan) equipped 
with a 40x water immersion lens (0.8 n.a., Olympus, Tokyo, Japan). Recordings were taken 
using borosilicate electrodes (4-8MΩ resistance) produced with a horizontal electrode puller 
(Model P-1000 Micropipette puller, Sutter Instruments, Novato, CA). The patch solution 
contained (in mM): 140 K-Gluconate, 1 MgCl2, 10 HEPES, 10 CaCl2, 2 ATP (Mg2+), and 0.4 
GTP (Na+), and 11 EGTA. The patch solutions also contained 0.2% biocytin (Sigma- Aldrich, 
St. Louis, MO) to identify the cell type of the patched cell (Teruyama & Armstrong, 2005, 
2007). The medium was saturated with 95% O2/5% CO2 and was warmed to 33-34°C during the 
recordings. ACSF contained picrotoxin and DNQX (100 and 10 µM, respectively) to suppress 
the synaptic activity. The ENaC current was estimated from the benzamil-sensitive current that 
was obtained from the difference in the steady state currents before and after the application of 
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benzamil (2 µM). Amiloride and its derivative benzamil are known potent blockers of the 
degenerin/epithelial sodium channel superfamily of ion channels and the Na+/H+ exchanger 
(NHE) and the Na+/Ca2+ exchanger (NCX); however, benzamil at the dosage used in this study 
(2 µM) is reasonably specific for ENaC as compared to the NHE and NCX (Kleyman & Cragoe, 
1988). 
Statistics 
Real-time PCR data were analyzed with the Student's t test for comparison between 
treatment groups and control. For semi-quantitative immunoblotting, densitometric 
measurements of bands were analyzed as comparison between control and aldosterone values for 
individual animals. Differences were considered to be statistically significant at p <0.05. Box-
and-Whisker plot were used to represent numerical data: the mean and median are represented by 
an open circle and a line, respectively; the box extends to the quartiles of data points; the 
whiskers extend to the farthest data points. 
Results 
Dose-response relationship of aldosterone and ENaC subunit expression  
The dose-response relationships of aldosterone and ENaC subunit gene expression were 
assessed by changes in the relative amount of mRNA for each of the subunits in response to 
incubation for 6 hr with aldosterone at concentration of 0.1 (n=6), 0.5 (n=15), 2.5 (n=12), and 
12.5 (n=6) µM. The expression of αENaC and βENaC did not change significantly in response 
to aldosterone at any concentration tested; however, the expression of γENaC was significantly 
higher on the side of hypothalamus that was incubated with aldosterone at 2.5 (p = 0.003) and 
12.5 (p = 0.038) µM compared to the side of the hypothalamus incubated with vehicle only. 
When the responses were plotted against log concentration of aldosterone, only the expression of 
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γENaC showed a graded dose-response (Fig. 2.1). Because the minimum concentration of 
aldosterone required to induce a significant level of γENaC expression within 6 hr was 2.5 µM, 





Fig. 2.1. Dose-response relationship of aldosterone and the expression of ENaC subunits. Semi-
log plots of changes in the relative amount of ENaC subunit mRNA in response to different 
concentrations of aldosterone. The expression of αENaC and βENaC did not change 
significantly at any concentration tested; however, the expression of γENaC was significantly 
higher on the side of hypothalamus that were incubated with aldosterone at 2.5 µM 
concentration compared to the side of the hypothalamus incubated with vehicle only.  
 
Aldosterone induces γENaC expression via the MR in the hypothalamus 
The effects of aldosterone on the expression of α-, β-, and γENaC subunits in the 
hypothalamus was assessed by changes in the relative amount of mRNA for each of the subunits 
(See Fig. 2.2). A significantly higher expression of γENaC was observed on the side of the 
hypothalamic slice that was incubated with aldosterone compared to the side incubated with 
vehicle only (Fig. 2.2A). In contrast to γENaC mRNA, no detectable effects of aldosterone on 
the amount of αENaC or βENaC mRNAs were observed. To determine if the effect of 
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aldosterone on the expression γENaC was mediated by the MR, one side of each hypothalamic 
slice was treated with a selective MR antagonist, RU-28318, prior to the application of 
aldosterone. The relative amount of γENaC mRNA was significantly lower on the side of the  
 
Fig. 2.2. The effect of aldosterone on ENaC subunit expression in hypothalamic slices. A. No 
significant difference in the relative amounts of αENaC and βENaC subunit mRNAs was 
identified between the aldosterone incubated and control side of hypothalamic slices; however, 
only the aldosterone incubated side had a significantly greater amount of γENaC subunit mRNA 
(*p<0.003). B. No significant differences in αENaC and βENaC subunit expression occurred 
between the sides of the hypothalamic slices that were pre-incubated with and without RU-
28318, respectively; however, the side of the hypothalamic slices that was not pre-incubated with 
RU-28318 had a significantly higher γENaC subunit expression compared to the side pre-
incubated with MR antagonist, RU-28318 (**p<0.034). C. No significant differences in αENaC, 
βENaC, or γENaC subunit expression observed between the sides of the hypothalamic slices that 
























































































































hypothalamic slices pretreated with the MR antagonist compared to the aldosterone-only treated 
side suggesting that the MR antagonist prevented the aldosterone induced γENaC expression 
(Fig. 2.2B). There were no detectable differences in the relative amounts of αENaC and βENaC 
subunit mRNAs between the RU28318 pretreated and non-treated groups (Fig. 2.2B). In 
addition, the treatment with RU28318 alone did not affect the relative amounts of αENaC, 
βENaC, or γENaC subunit mRNAs (Fig. 2.2C). 
 Semi-quantitative immunoblotting was also performed to assess whether the abundance 
of ENaC subunit proteins changed in response to aldosterone. Distinct bands at the predicted 
molecular weights of 87 kDa and 85 kDa in protein extract from the hypothalamus were detected 
by αENaC and γENaC antibodies, respectively (Fig. 2.43A). No detectable band was labeled by 
the βENaC antibody in the protein extracted from the hypothalamus (Fig. 2.3A), although a band 
at the predicted molecular weight of 88 kDa was labeled by the βENaC antibody in the protein 
extract from the kidney cortex (data not shown). The abundance of γENaC protein increased 
significantly on the side of hypothalamic slice that was incubated with aldosterone; however, the 
abundance of αENaC protein was unchanged (Fig. 2.3B).  
 Furthermore, Chromatin Immunoprecipitation (ChIP) was performed to assess 
whether the aldosterone-MR complex directly binds to the promoter region of the γENaC gene 
(Scnn1g). MR antibodies were used to precipitate fractions of DNA containing the MR. Real-
time PCR with a specific primer set detected the promoter region of Scnn1g in the MR-
immunoprecipitated DNA fractions (Fig. 2.4). Results from this experiment indicate that the MR 
binds directly to the promoter region of the γENaC DNA, and suggests that binding of the MR-





Fig. 2.3. The effect of aldosterone on ENaC subunit proteins abundance in hypothalamic slices. 
A. Immunoblots showing the effect of aldosterone on the abundance and molecular weight of 
each ENaC subunit in the hypothalamic slices from 7 different animals. For each blot, each lane 
was loaded with the protein extract from a side of hypothalamic slices from an individual animal. 
The first seven lanes represent the side of the hypothalamic slice that were treated only with 
vehicle, whereas the following seven lanes represent side of slices that were treated with 
aldosterone. Antibodies against αENaC, γENaC, and GAPDH detected a single band at the 




line.		The treatment with aldosterone resulted in no change in the band density of αENaC 




Fig. 2.4. Chromatin Immunoprecipitation (ChIP) with MR antibody. A. Schematic representation 
of the genomic structure of Scnn1-g and the relative position of the primer set used for ChIP 
experiments. The 13 exons of Scnn1-g are indicated with vertical lines and boxes. B. MR-ChIP 
experiments using chromatins prepared from rat brain and kidney.  The DNA from input 
controls, immunoprecipitates with anti-MR antibody (Ab+), and negative controls (Ab-) were 
used for PCR amplification. C. The reduced level of Ab- expression and similar expression of 
Ab+ in comparison to input control was further analyzed with qPCR.  Shown are the relative 
amount of immunoprecipitated DNA and negative control compared to those from input control. 
Experiments performed by: K. Sharma 
 
Corticosterone induces γENaC expression through the GR in the hypothalamus 
The effect of corticosterone on the expressions of the α, β, and γ ENaC subunits in the 
hypothalamus was also assessed by determining the relative amount of mRNA for each of the 
subunits. Incubation with corticosterone caused a significantly higher γENaC subunit expression 
in the hypothalamic slice; however, no detectable effects were observed in the expression of the 



























 Because the MR has a similar binding affinity for both mineralocorticoids and 
glucocorticoids (Funder, 1995), experiments were performed to determine if the MR mediated 
the effect of corticosterone on γENaC expression. One side of the hypothalamic slices was pre-
treated with the MR-antagonist, RU-28318, prior to the application of corticosterone, while the 
other side was treated with corticosterone only. No significant difference was detected in the 
relative amounts of mRNAs for all ENaC subunits between the corticosterone-only treated side 
of the hypothalamic slices and those treated with the MR antagonist and corticosterone (Fig. 
2.5B), indicating pretreatment with RU-28318 failed to block an increase in γENaC mRNA by 
corticosterone in hypothalamic slices.  
 Because the MR antagonist was unable to attenuate the effects of corticosterone on 
γENaC expression, it was likely that corticosterone bound to the GR to induce γENaC expression 
in the hypothalamus. To test this hypothesis, one side of the hypothalamic slices was pre-treated 
with RU-486, a selective GR antagonist, prior to the application of corticosterone, while the 
other side was treated with corticosterone only. The relative amount of γENaC mRNA was 
significantly lower on the side of hypothalamic slices treated with RU486 compared to those 
treated with corticosterone only; also, there were no detectable differences in αENaC or βENaC 
expression between the treatment groups (Fig. 2.5C). In addition, the treatment with RU486 
alone did not affect the relative amounts of αENaC, βENaC, or γENaC subunit mRNAs (Fig. 
2.5D). Taken together, these results indicate that GR antagonism was able to attenuate the effect 
of corticosterone on γENaC expression.  These results suggest an independent pathway involving 




Fig. 2.5. The effect of corticosterone on ENaC subunit expression in hypothalamic slices. A. No 
significant differences in the relative amounts of αENaC and βENaC subunit mRNAs occurred 
between the respective sides of the hypothalamic slices that were incubated with and without 
corticosterone, respectively; however, the sides that were incubated with corticosterone had a 
significantly higher γENaC subunit expression compared to those sides incubated with vehicle 
only (*p<0.007). B. No significant differences in αENaC, βENaC, or γENaC subunit expression 
occurred between the sides of the hypothalamic slices that were pre-incubated with and without 
MR antagonist, RU-28318, respectively. C. No differences in αENaC and βENaC subunit 
expression occurred between the hypothalamic slices that were pre-incubated with and without 
GR antagonist, RU486, respectively; however, the hypothalamic slices that were not pre-
incubated with RU486 had a significantly higher γENaC subunit expression compared to those 
pre-incubated with RU486 (**p<0.037). D. No significant differences in αENaC, βENaC, or 
γENaC subunit expression observed between the sides of the hypothalamic slices that were 


























































































































































Subcellular distribution of ENaC subunit immunoreactivity   
In the region of the hypothalamus used for semi-quantification of the ENaC subunit 
mRNAs and proteins in the present study, immunoreactivity of the ENaC subunits was 
exclusively found in magnocellular neurons in the SON and PVN (Fig. 2.6 A&B). No 
immunoreactivity of ENaC subunits was observed in the ependymal cell layers or in the 
endothelium of blood vessels. Because our recent study showed αENaC labeling was 
distinctively concentrated near the plasma membrane in neurons from animals that were fed a 
high salt diet (Sharma et al., 2017), the effect of aldosterone on the subcellular distribution of 
ENaC subunits immunoreactivity was also examined. Intense αENaC immunoreactivity that was 
moderately concentrated towards the plasma membrane was observed in most of the 
magnocellular neurons; however, no noticeable differences in subcellular distribution of ENaC 
immunoreactivity occurred between control and aldosterone treated hypothalamic slices from six 
different animals (Fig. 2.6C). Weak immunoreactivity of βENaC was observed in the cytoplasm 
of magnocellular neurons (Fig. 2.6C). In contrast to βENaC immunoreactivity, γENaC 
immunoreactivity was intense and fully filled the cytoplasm of magnocellular neurons (Fig. 
2.6C).  
Effect of corticosteroids on vasopressin expression 
 
 In the kidney, VP promotes Na+ reabsorption by inducing the expression of β- and γ-
ENaC subunits (Djelidi et al., 1997; Ecelbarger et al., 2000; Nicco et al., 2001; Sauter et al., 
2006) and the translocation of intracellular pools of pre-existing ENaC subunits to the apical 
membrane of the principal cells in the collecting duct (Schafer & Hawk, 1992). The effect of 
aldosterone and corticosterone on the expression of VP was assessed to evaluate possible effect 
of corticosteroid-induced VP on ENaC activity. Semiquantitative PCR found that neither 
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incubation with aldosterone nor corticosterone produced changes in expression of VP in the 





Fig. 2.6. Immunocytochemical localization of γENaC in the hypothalamic slices. A. 
Immunoreactivity to γENaC was exclusively found in the magnocellular neurons in both the 
SON and SON. Although a limited number of neurons located in the area between the SON and 
PVN were also immunoreactive to γENaC; no other prominent immunoreactivity was found in 
the hypothalamic slices. B. In the SON, immunoreactivity to γENaC was exclusively found in 
the magnocellular neurons.  C. Confocal microscopy of αENaC, βENaC, and γENaC 
immunoreactivities in magnocellular neurons in the SON from hypothalamic slices that were 
treated with aldosterone and vehicle only. The αENaC immunolabeling within neurons was 
moderately concentrated towards the plasma membrane; no noticeable differences in subcellular 
distribution of αENaC immunoreactivity occurred between control and aldosterone treated 
hypothalamic slices. Intense γENaC immunoreactivity fully filled the cytoplasm. No noticeable 
differences in subcellular distribution of βENaC or γENaC immunoreactivity occurred between 
control and aldosterone treated hypothalamic slices. 1 µm optical section. Scale bars: 500 µm in 














Fig. 2.7. The effect of corticosteroids on VP expression in hypothalamic slices. A. No significant 
differences occurred in the relative amounts of VP mRNA identified between the aldosterone 
and vehicle only incubated sides of the hypothalamic slices. B. No significant differences 
occurred in the relative amounts of VP mRNA identified between the sides of hypothalamic 
slices that were incubated with and without corticosterone. 
 
Effect of aldosterone on the benzamil-sensitive current 
Of forty-five recorded VP neurons from 21 rats, 25 neurons were from the aldosterone-
treated side, and 20 neurons were from the control side. From these recorded VP neurons, 12 
(48%) recorded neurons from the aldosterone-treated sides and 6 (30%) recorded neurons in the 
control sides showed a decrease (> 2.5 pA) in the steady state inward current held at -80 mV in 
response to the application of benzamil (Fig. 2.4.8A). The benzamil-sensitive current was 
obtained from the difference in the steady state currents before and after the application of 
benzamil. The mean benzamil-sensitive current was similar in VP neurons from both the 
aldosterone-treated (13.1 ± 3.8 nA) and control (11.7 ± 5.4 nA: Fig. 2.4.8B) sides. The effect of 






Fig. 2.8. The effect of aldosterone on benzamil-sensitive current.  Aa. An example of the effect 
of benzamil on the steady state current in a VP neuron. The steady state current was measured in 
voltage clamp while the cell was held at -80 mV. Ab. Brief hyperpolarizing pulses (15 mV, 200 
ms) were injected every 5 s to monitor the input resistance of the cell. Bath application of 
benzamil (2 µM) reduced the resting inward current and decreased conductance by 
approximately 1.5-fold. A benzamil sensitive current was obtained by changes in the steady state 
current in response to its application. B. The mean benzamil-sensitive current did not differ in 
VP neurons from the aldosterone-treated and control sides. C. The mean whole cell membrane 
capacitance of VP neurons did not differ between the aldosterone-treated side and that from the 
control sides. D. There was no difference in the mean benzamil sensitive current density in VP 














































The mean whole cell membrane capacitance did not differ between the aldosterone-
treated (27.79 ± 2.55 pF) and control (23.02 ± 2.41 pF) sides, indicating that a hypertrophy of VP 
neurons did not occur in response to the aldosterone exposure (P=0.252; Fig. 2.4.8B). 
Subsequently, the benzamil-sensitive current was normalized by the whole-cell capacitance, and 
the current density (pA/pF) was obtained. The mean current density (0.47 ± 0.16 nA/pF) of VP 
neurons from the aldosterone treated hypothalamic slices did not differ from that (0.57 ± 0.18 
nA/pF: Fig. 2.4.8C) in VP neurons from the control hypothalamic slices.  
Discussion 
Aldosterone directly induced the expression of γENaC via MR in VP neurons 
The present study demonstrated that incubation of hypothalamic slices with aldosterone 
resulted in induction of γENaC subunit expression, whereas αENaC and βENaC subunit 
expression remained at basal levels. Antagonism of the MR attenuated the effect of aldosterone 
on γENaC expression, indicating that aldosterone induced γENaC genomic change via the MR in 
the hypothalamic slices. Moreover, the result from our ChIP experiment indicated that the 
aldosterone-MR complex directly interacts with the hormone-responding element on the γENaC 
gene. The structures that express ENaC were found only in magnocellular neurons in the PVN 
and SON in the hypothalamic slices used in this study. γENaC immunoreactivity was identified 
prominently in the VP neurons in the SON and PVN in our previous study (Teruyama et al., 
2012a), suggesting the aldosterone-MR mediated regulation of γENaC expression most likely 
occurred specifically in VP neurons. 
Corticosterone induces the expression of γENaC via GR in VP neurons 
Another major finding of the present study is that corticosterone incubation resulted in a 
significant increase in γENaC expression, similar to the expressional changes observed 
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subsequent to aldosterone incubation. Because corticosterone binds to both the GR and MR with 
similar affinity (Beaumont & Fanestil, 1983; Krozowski & Funder, 1983; Reul & de Kloet, 
1985; Sheppard & Funder, 1987a; Sheppard & Funder, 1987b; Funder, 1995), antagonists for 
MR and GR were used to elucidate which receptor was activated to induce the γENaC 
expression. Antagonism of the MR was unable to prevent this effect of corticosterone on γENaC 
expression; however, an antagonist of the GR did attenuate induction of γENaC expression in the 
presence of corticosterone. These results indicate that corticosterone preferentially binds to the 
GR rather than to the MR in VP neurons to induce γENaC expression.  
 Although plasma concentrations of glucocorticoids are substantially higher than those of 
aldosterone (Holbrook et al., 1980), aldosterone is known to preferentially bind to the MR in 
aldosterone sensitive-epithelia (Odermatt et al., 2001). Aldosterone selectivity of the MR in the 
epithelia is achieved by inactivating intracellular glucocorticoids through the glucocorticoid-
inactivating enzyme, 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2) (Gomez-Sanchez et 
al., 2005b), which converts corticosterone into inactive metabolites (Funder, 1995; Naray-Fejes-
Toth et al., 1998). Thus, our present observation may be explained by our previous finding that 
11β-HSD2 is expressed in the MR-expressing neurons in the SON and PVN (Haque et al., 
2015). 
Regulation of γENaC in VP neurons by aldosterone and corticosterone 
Both the MR and GR belong to the nuclear receptor super family that act as transcription 
factors regulating gene expression (Vallon et al., 2005; Ronzaud et al., 2007; Ackermann et al., 
2010). Upon hormone binding in the cytosol, the MR forms homodimers and heterodimers with 
the GR and is translocated into the nucleus where it binds to the hormone-responsive element of 
the target gene (Ou et al., 2001; Gekle et al., 2014). Since the DNA binding domains of the MR 
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and GR share approximately 94% amino acid homology (Viengchareun et al., 2007), both the 
MR and GR are thought to bind the common hormone-responsive elements in a sequence-
specific manner to regulate some of the same genes (Evans & Arriza, 1989). The present finding 
that corticosterone-GR induced γENaC expression in a manner similar to that of aldosterone-MR 
in the hypothalamus may be due to the activation of common hormone-responsive elements on 
γENaC by the GR and MR.  
Aldosterone alone does not cause increase in ENaC activity in VP neurons  
Our recent study showed that the enhanced ENaC activity in response to high dietary salt 
intake was associated with an increase in the expression of both βENaC and γENaC subunits in 
the SON, as well as translocation of ENaC towards the plasma membrane (Sharma et al., 2017). 
These changes in the expression of the βENaC or the subcellular translocation of ENaC were not 
observed in the hypothalamic slices exposed to aldosterone in vitro. Therefore, other factors 
involving in induction of βENaC and translocation of ENaC to fully activate ENaC in VP 
neurons were not activated in the hypothalamic slices in media with aldosterone. 
 VP is known to induce the expression of βENaC subunits in the kidney (Djelidi et al., 
1997; Ecelbarger et al., 2000; Nicco et al., 2001; Sauter et al., 2006). Of the three characterized 
VP receptor subtypes (V1a, V1b, and V2), VP appears to act through the V2 VP receptor to 
induce gene expression of βENaC (Nicco et al., 2001) in the kidney. VP also stimulates the 
translocation of intracellular pools of pre-existing ENaC subunits to the apical membrane of the 
principal cells in the collecting duct promoting Na+ reabsorption in the kidney (Schafer & Hawk, 
1992). VP neurons not only secrete VP at nerve terminals in the neurohypophysis, but also 
release VP from their soma and dendrites in the extracellular space of the SON and PVN 
(Landgraf & Ludwig, 1991; Neumann et al., 1993; Ludwig, 1998). The V2 receptor was shown 
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to mediate the ability of the somato-dendritically released VP to facilitate cell volume regulation 
in VP neurons (Sato et al., 2011). The presence of V2 receptors on VP neurons suggests the 
possibility that βENaC in VP neurons could be regulated by the somato-dendritic release of VP 
by mechanisms similar to their regulation in the nephron. Unlike high dietary salt intake, 
aldosterone did not cause an increase in VP expression in this study. Thus, the lack of 
enhancement in VP expression in response to aldosterone treatment may be the reason for the 
lack of a change in βENaC expression and translocation of ENaC in VP neurons.  
Effect of aldosterone on ENaC in the brain in vivo 
Our recent study (Sharma et al., 2017) found that a NaCl deficient diet, which is known 
to cause an increase in aldosterone in the general circulation (Frindt et al., 1990; Pacha et al., 
1993; Asher et al., 1996), did not cause a change in ENaC expression in the SON. However, the 
NaCl deficient diet did cause an increase in αENaC mRNA in the kidney known to occur in 
response to elevated aldosterone caused by such a diet (Renard et al., 1995; Asher et al., 1996; 
Escoubet et al., 1997; Stokes & Sigmund, 1998b; Masilamani et al., 1999; MacDonald et al., 
2000). Instead, a high NaCl diet, which is known to decrease circulating aldosterone, caused an 
increase in βENaC and γENaC mRNAs in the SON (Sharma et al., 2017). This finding implies 
that plasma aldosterone has no effect on ENaC expression in VP neurons. Despite the 
lipophilicity of steroids, aldosterone is known to have a surprisingly poor penetration of the 
blood-brain barrier (BBB) (Pardridge & Mietus, 1979; Funder & Myles, 1996; Parker et al., 
2006). This also agrees with the finding in rats that subcutaneous infusion of aldosterone 
increased plasma aldosterone level without significant changes in hypothalamic aldosterone 
content (Huang et al., 2010). Therefore, the induction of γENaC expression in VP neurons by 
plasma aldosterone in vivo is somewhat questionable.   
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 One possible explanation for this is that aldosterone-MR-ENaC pathway in the brain is 
regulated independently of the peripheral/renal pathway. A growing body of evidence now 
suggests that aldosterone is synthesized in the CNS. The ability of brain tissue to synthesize 
aldosterone was demonstrated in vitro (Gomez-Sanchez et al., 2005a). Transcripts of aldosterone 
synthase (CYP11B2) were detected in various brain regions including the hypothalamus 
(MacKenzie et al., 2000). The presence of aldosterone synthase was detected by in situ 
hybridization in magnocellular neurons in the SON (Wang et al., 2016). Furthermore, ICV 
infusion of Na+-rich ACSF caused in rats an increase in hypothalamic aldosterone concentration 
and blood pressure, and both were prevented by ICV infusion of an aldosterone synthase 
inhibitor (Huang et al., 2008). Thus, aldosterone synthesis in the hypothalamus may be 
stimulated by a high concentration of Na+ in the CSF. Together with the present finding that 
γENaC in the hypothalamus is induced by aldosterone, the high-salt diet induced expression of 
γENaC in the SON found in our previous study was mediated by aldosterone that was 
synthesized locally.  
 Another possible explanation is that high dietary salt intake affects gene expression of 
γENaC via the glucocorticoid-GR pathway, instead of or in addition to the locally synthesized 
aldosterone-MR pathway. The present study showed corticosterone induced γENaC expression 
via GR in the hypothalamus. Thus, it is possible that the stress induced by high dietary salt intake 
increased the circulating level of corticosterone that crossed the BBB and affected γENaC 
expression via the GR.  
Limitations of this study  
The physiological plasma concentration of aldosterone (<0.1 µM) did not induce gene 
expression of ENaC subunits in in vitro hypothalamic slices. The concentration of aldosterone 
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used in this study was supra-physiological. For humans, this aldosterone concentration in plasma 
would be above the pathological range (Mattsson & Young, 2006). The supra-physiological dose 
was probably required for aldosterone to penetrate the relatively thick 250 µm hypothalamic 
slices without a functional vascular system. One of the concerns for using a supra-physiological 
concentration of corticosteroids is that these steroids may bind to other steroid receptors at that 
concentration. However, the effects of aldosterone and corticosterone on γENaC expression was 
attenuated by both MR and GR antagonists, respectively. In addition, the effect of corticosterone 
on γENaC expression was not attenuated by a MR antagonist, suggesting that the high 
concentration of the MR antagonist did not affect off-target receptors. Considering the presence 
of MRs in VP neurons (Teruyama et al., 2012a; Haque et al., 2015) and the direct interaction of 
MR with the hormone responding element on the γENaC gene in the SON demonstrated by the 
present ChIP experiment, it is reasonable to interpret that aldosterone induces the expression of 
γENaC in VP neurons.  
Physiological relevance and Conclusion 
Several in vivo studies suggest that ENaC in the brain are activated by aldosterone. In 
normotensive rats, ICV infusion of aldosterone increases blood pressure (Wang & Leenen, 2002, 
2003). In salt-sensitive Dahl rats, high-salt diet or ICV infusion of aldosterone causes 
hypertension, but ICV infusion of a MR antagonist prevents the development of hypertension 
(Gomez-Sanchez et al., 1992). Intriguingly, ICV infusion of amiloride or benzamil prevents salt-
induced hypertension in salt-sensitive Dahl rats (Gomez-Sanchez & Gomez-Sanchez, 1994; 
Wang & Leenen, 2002), as well as the hypertension induced by ICV infusion of aldosterone in 
normal rats (Gomez-Sanchez & Gomez-Sanchez, 1995). These findings suggest that aldosterone-
mediated ENaC activation in the brain is involved in the regulation of blood pressure.  
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 ENaC subunits and MR in the brain are colocalized only in limited regions, namely the 
SON, PVN, subfornical organ, choroid plexus, and ependyma of the anterovental third ventricle 
(Amin et al., 2005; Teruyama et al., 2012a; Haque et al., 2015). In these brain structures, VP 
neurons in the PVN and SON are the only structures that directly stimulate both endocrine and 
autonomic responses to maintain cardiovascular homeostasis. In addition to the well-
characterized endocrine role of VP on antidiuretic and pressor effects, the somato-dendritic 
release of VP stimulates the activity of parvocellular neurons that project to the rostral 
ventrolateral medulla (Son & Stern, 2011), thereby leading to increase in both sympathetic 
outflow and blood pressure (Dampney, 1994).  
ENaC in VP neurons mediate a steady state Na+ leak current that regulates the basal 
membrane potential (Teruyama et al., 2012a; Sharma et al., 2017). More depolarized basal 
membrane potential observed in VP neurons in response to high dietary salt intake was caused 
by increased ENaC expression and activity (Sharma et al., 2017). Therefore, activation of ENaC 
raises the basal membrane potential closer to the action potential threshold and consequently 
augments synaptic drive. Because the release of VP is regulated largely by the frequency and 
pattern of action potential firing in their synthesizing neurons (Poulain & Wakerley, 1982; 
Cazalis et al., 1985), ENaC activity in VP neurons could directly influence the release of VP and 
autonomic responses. Thus, the physiological conditions that require VP, such as an excess 
dietary salt intake, may promote release of VP through ENaC activation. 
The present study identified a direct involvement of aldosterone and corticosterone on 
γENaC expression in VP neurons via the MR and GR, respectively. Thus, aldosterone and 
corticosterone are likely involved in activation of ENaC in VP neurons in response to the 
physiological demand for VP. However, aldosterone itself is not sufficient to induce activation of 
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ENaC in VP neurons, as neither induction of βENaC subunits nor translocation of ENaC to the 
plasma membrane were observed after incubation with aldosterone. Therefore, the mechanism 
underlying the regulation of ENaC activity in VP neurons remains largely unknown. 
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EFFECT OF DIETARY SALT ON EPITHELIAL NA+ CHANNELS (ENAC) 
IN THE HYPOTHALAMUS OF DAHL SALT-SENSITIVE RATS 
 
Introduction 
 In the paraventricular (PVN) and supraoptic nuclei (SON) of the hypothalamus, 
magnocellular neurosecretory cells (MNCs) synthesize the neurohypophysial hormones, 
vasopressin (VP) and oxytocin (OT).  Synthesis and release of VP into the general circulation is 
promoted by physiological demands to maintain body fluid homeostasis. During times of 
hyperosmolarity (Brimble & Dyball, 1977), hypovolemia (Harris et al., 1975), and hypotension 
(Khanna et al., 1994), VP release is enhanced to produce pressor and antidiuretic effects to 
counter these physiological changes (Antunes-Rodrigues et al., 2004). Additionally, VP is 
released from the soma and dendrites of VP neurons located in the PVN to enhance the activity 
of the parvocellular neurons that project to the rostral ventrolateral medulla to cause an increase 
in sympathetic outflow and blood pressure (Son et al., 2013). Given these systemic effects of 
VP, it is clear that VP plays an essential role in coordinating neuroendocrine and autonomic 
activities to maintain cardiovascular homeostasis.  
 The non-voltage dependent, amiloride-sensitive, epithelial Na+ channel (ENaC) is 
expressed within the apical membrane of the epithelium involved in trans-epithelial Na+ 
transport (Canessa et al., 1994; Harris et al., 2008), such as the distal colon and renal collecting 
duct in the kidney (Kellenberger & Schild, 2002). ENaC expression was also demonstrated in 
various regions of the brain involved in cardiovascular control, such as the PVN, SON and 
choroid plexus (Amin et al., 2005). Our previous study showed that all ENaC subunits (α, β, and 
γ) are expressed specifically in VP MNCs, and functional ENaC channels modulate the 
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membrane potential of VP neurons by mediating a Na+ leak current (Teruyama et al., 2012). 
Additionally, we demonstrated the mineralocorticoid receptor (MR), a known ENaC regulator, is 
present in VP neurons (Teruyama et al., 2012; Haque et al., 2015).  
 It is well-known that dietary salt regulates ENaC expression in aldosterone-sensitive 
epithelia (Garty & Palmer, 1997; Stokes & Sigmund, 1998), such as the renal collecting duct 
(Masilamani et al., 1999). Interestingly, central administration of amiloride, an ENaC blocker, 
and its analog, benzamil, attenuates hypertension in several animal models of hypertension 
(Gomez-Sanchez & Gomez-Sanchez, 1994, 1995; Nishimura et al., 1998; Keep et al., 1999). 
Additionally, we recently demonstrated that ENaC activity in VP neurons is affected by 
increased dietary salt intake in normotensive rats (Sharma et al., 2017). These findings suggest 
that central ENaC expression and activity are involved in hypertension development. The effect 
of dietary salt on ENaC expression within VP neurons during salt-sensitive hypertension remains 
unknown. The present study was conducted to examine ENaC expression during high dietary salt 
intake in salt-sensitive states utilizing Dahl salt sensitive (Dahl-SS) rats, an established animal 
model for salt-sensitive hypertension (Rapp, 1982). Findings from this study indicate that ENaC 
expression within VP neurons is altered in Dahl-SS rats during high dietary salt intake, which 
may provide some insight into the etiology of salt-sensitive hypertension.  
Methods 
Animals  
Male Sprague Dawley (SD) and Dahl-SS rats (ENVIGO, Indianapolis, IN) weighing 
between 260-300g were used for this study.  Rats were housed on a 12:12 hr light-dark cycle. All 
protocols were approved by the Institutional Animal Care and Use Committees of Louisiana 
State University.  
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Tissue Sample for Real-time RT-PCR and Semiquatitative immunoblotting  
Rats were fed standard chow (0.4% NaCl) or high salt (8% NaCl) (Teklad diet 
Indianapolis, IN) for 21 days and water ad libitum. On the 21st day, animals were sacrificed and 
tissue was collected for real-time RT-PCR or semiquatitative immunoblotting. Rats were deeply 
anaesthetized using Ketamine-Xylazine (9:1, 100 mg/kg i.p.) and approximately 1 ml of blood 
was collected from each anesthetized animal by a 21-gauge needle inserted into the left ventricle 
directly before cardiac perfusion. Animals were then perfused through the heart with cold 
artificial cerebral spinal fluid (aCSF), in which NaCl was replaced by equiosmolar amount of 
sucrose containing (in mM): 210 Sucrose, 3 KCl, 2.0 CaCl2, 1.3 MgCl2, 1.24 NaH2PO4, 
25 NaHCO3, 0.2 ascorbic acid, and 10 D-glucose (pH 7.4). Brains were removed and three 
coronal slices (500 µm) containing the SON and PVN were collected using a vibrating 
microtome (Leica VT1200; Leica, Mannheim, Germany). Slices were trimmed along the dorsal 
and lateral edges to exclude tissue that did not contain the PVN and SON and then stored in 
RNAlater (Qiagen, Valencia, CA) at -20 °C for real-time RT-PCR or RIPA Buffer (Sigma-
Aldrich, St Louis, MO) and processed for semiquatitative immunoblotting. Additionally, during 
tissue collection for real-time RT-PCR, one of the kidneys from each animal was also removed, 
minced, and saved in RNAlater for processing.  
Real-time RT-PCR  
Total RNA was isolated using TriReagent (Sigma-Aldrich, St Louis, MO) according to 
the manufacture’s instructions and tissue was homogenized using a tissue lyser (Qiagen, CA). 
Lysate was then treated with chloroform (Thermo-Fisher Scientific) and centrifuged at 12,000 
rpm for 15 min. Total RNA was precipitated from the aqueous phase using isopropyl alcohol and 
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washed with ethanol. The precipitate was suspended in 20 µl RNAase-free water (Qiagen, CA). 
Concentration and quality of isolated RNA was assessed using a spectrophotometer (NanoDrop 
1000, ThermoFisher Scientific, Waltham, MA). Isolated mRNA was reverse transcribed to 
cDNA using oligo dT and M-MLV reverse transcriptase (Sigma-Aldrich, St. Luis, MO) and used 
in real-time RT-PCR analysis. ABI ViiA-7 sequence detection system (ABI Applied Biosystem, 
Grand Island, NY) was used in conjunction with SYBR Select Master Mix (ABI Applied 
Biosystem, Grand Island, NY). All samples were measured with three replicates and the two 
closest cycle threshold (Ct) values were averaged for each sample.  Quantitative PCR primers 
were designed using Primer 3 software (Whitehead Institute for Biomedical Research) and 
purchased from Sigma-Aldrich (St. Louis, MO). All primer sequences were specifically designed 
to amplify the cDNA of interest (Table 1) and have been used successfully (Amin et al., 2005; 
Teruyama et al., 2012). The effect of the treatments was examined through the relative change of 
the specific target genes, which were calculated through the comparative cycle threshold method. 
For each sample, the average cycle threshold (Ct) value of the target gene was subtracted by the 
housekeeping (Cyclophilin B) Ct value to obtain the ΔCt value. The ΔCt values of the designated 
control group were averaged and subtracted from each sample to generate the ΔΔCt value. The 
relative change was calculated for each sample by using the formula 2 - ΔΔCt. All results are 
shown as relative change in comparison to the control. The Student’s t test was used for 
comparison between treatment groups. Differences were considered to be statistically significant 
at p< 0.05.  
Plasma osmolality 
Collected blood samples were centrifuged at 12,000 rpm for 20 min at 4 °C and the 
supernatant was collected and placed in a chilled 1.5 ml centrifuge tube. The collected 
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supernatant was centrifuged for 5 min at 12,000 rpm at 4 °C, and the resulting supernatant was 
collected and stored at -20° C for later processing. Osmolality of the blood samples was 
measured using an osmometer (5004 Micro-osmette, Precision System Inc., Natick, MA). The 
Student’s t-test was used for comparison between treatment groups. Differences were considered 
to be statistically significant at p< 0.05. 
Semiquatitative immunoblotting 
 Total protein lysate samples were collected from the hypothalamic slices. Tissue samples 
were rinsed with cold phosphate buffer solution and placed in microcentrifuge tubes containing 
250 µl of chilled complete lysis buffer that was made fresh before each experiment. Complete 
buffer contained: RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium 
deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0; Sigma-Aldrich), protease inhibitors 
(ProteoGuardTM EDTA-free protease inhibitor cocktail; Takara Clontech), 1 mM EGTA, 1 mM 
EDTA, and 1mM DTT (Sigma-Aldrich, St. Louis, MO). Samples were briefly homogenized with 
an electric tissue lyser (Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed 
samples were centrifuged for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the 
supernatant (total lysate) was transferred to a clean tube to be stored at -20°C for later 
processing.  
 The protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford, 
Illinois, USA); samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer 
(Bio-Rad, Hercules, CA) for 5 min at 95 °C. Samples were resolved in a 4-15% SDS-PAGE 
(Mini PROTEAN Precast Gels, Bio-Rad, Hercules, CA) gradient gel in Tris-glycine buffer (25 
mM, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) and transferred to a PVDF membrane (Bio-
Rad, Hercules, CA) under wet conditions (50V for 2 hr at 4°C). To determine a successful 
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transfer, the membrane was stained with Ponceau S solution (Sigma-Aldrich, St. Louis, MO) for 
approximately 1 min. The membrane was destained with 0.1 M NaOH for 30 sec followed by a 1 
min TBST (Tris-GlycineTween; 50 mM Tris base, 200 mM NaCl, 0.05% Tween 20) wash. The 
membrane was treated with 5% non-fat milk buffer (NFM; Bio-Rad) for 1 hr at room temp. The 
membrane was incubated overnight at 4 °C with the selected primary antibody dissolved in 5% 
NFM buffer. A final concentration for all primary antibodies was 1 µg/ml. The membrane was 
washed three times for 10 min each with TBST and incubated with goat-anti-rabbit horseradish 
conjugated secondary antibody (1:10,000; Bio-Rad) dissolved in 5% NFM buffer at room temp 
for 2 hr followed by six TBST washes for 10 min each. Protein bands were detected through 
chemiluminscence reagents (ClarityTM Western ECl Substrate Kit; Bio-Rad) and imaged using a 
gel imaging system (ChemiDocTM XRS+; Bio-Rad). Densitometric analyses of the images were 
performed using ImageJ (National Institutes of Health, Bethesda, MD). Measurements were 
normalized by subtracting background values of the collected image. Densometric measurements 
were analyzed as a comparison between rat strain and dietary treatment for individual animals 
using a Student’s t-test and considered significantly different at p<0.05.  
Immunocytochemistry 
Rats fed high salt or control diet for 21 days were deeply anaesthetized using Ketamine-
Xylazine (9:1, 100 mg/kg i.p.) and transcardially perfused with 0.01 M sodium phosphate 
buffered saline (PBS, pH 7.2) followed by 4% paraformaldehyde in 0.1 M PBS (pH 7.2). 
Animals were decapitated and the heads were postfixed in the same fixative for 1-3 days. Brains 
were removed and placed in 20% sucrose in 0.1 M PBS overnight for cryoprotection. Coronal 
sections at 40 µm were collected by a sliding microtome (SM2010R; Leica, Mannheim, 
Germany). Slices were incubated with the primary antibody against γENaC at a dilution of 
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1:4,000 in PBS containing 0.5% Triton X-100 (PBST) at 4 °C with continuous, gentle agitation 
overnight. The antibodies used for the ENaC subunits were a generous gift from Dr. Mark A. 
Knepper (National Institutes of Health, Bethesda, MD) and were previously described in great 
detail (Masilamani et al., 1999). Slices were incubated with biotinylated goat-anti-rabbit IgG 
(1:500 in PBST; Vector, Burlingame, CA) for 2 hr followed by incubation with the ABC 
complex (1:500 in PBST, Vector, Burlingame, CA) for 1 hr at room temperature. Finally, slices 
were incubated with diaminobenzidine (DAB; Vector, Burlingame, CA) for 6 min to visualize 
immunoreactivity. The brains were mounted on gelatin-coated slides, dehydrated, cleared, and 
cover slipped with Permount (Thermo Fisher Scientific, Waltham, MA). Images were acquired 
digitally (Eclipse 80i equipped with a digital camera, DS-QiMc, Nikon, Tokyo, Japan). Digital 
images of both sides of the SON were acquired from each animal and analyzed using ImageJ 
(National Institutes of Health, Bethesda, MD). The total number of immunoreactive cells was 
obtained using the Cell Counter ImageJ plugin and densometric measurements of each cell were 
assessed for each animal. Background measurements were collected for each section and cell 
optical density measurements were subtracted to obtain normalized values. Normalized 
measurements that had an optical density 75% higher than the background measurement was 
classified as having dense immunocytochemistry staining. Measurements were analyzed using a 
Student’s t test and considered significantly different at p<0.05. 
Time course plasma osmolality collection	
A separate set of male SD and Dahl-SS rats were used to measure the changes in plasma 
osmolality over time in response to dietary salt. Blood samples (0.1ml) were collected every 
morning, alternating between left and right tail veins. Samples were stored in 4 °C for 30 min to 
let the blood clot and centrifuged at 10,000 rpm for 8 min at 4 °C. The supernatant was collected 
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to check the osmolality as described above. After the initial seven days of sampling on control 
diet to measure the baseline plasma osmolality of each animal, all rats were fed high salt (8% 
NaCl) diet ad libitum for 22 days with free access to drinking water.  
Results 
Dietary salt increases hypothalamic γENaC, OT, and VP expression in Dahl-SS rats 
The effect of dietary salt on the expression of ENaC subunits, VP, OT, and MR in the 
hypothalamus of Dahl-SS rats was assessed by the relative difference in amount of mRNA 
between groups for each of the genes (See Fig. 3.1). Significantly higher γENaC subunit 
expression was observed in Dahl-SS rats fed a high salt diet compared to those fed the control 
diet (p=0.025). In contrast, there was no difference in the α- and βENaC subunit expressions 
between dietary treatments. Expression of VP and OT was also significantly increased in 
response to high dietary salt compared to that of the control diet (p=0.007 and p=0.011, 
respectively). Additionally, ENaC expression in the kidney was examined in Dahl-SS rats fed 
control or high salt diet. In contrast to hypothalamic ENaC expression, no difference was 
observed in kidney ENaC subunit expression between treatment groups (Fig. 3.1B). 
SD rats fed high dietary salt have decreased αENaC in the kidney and MR 
expression in the hypothalamus 
 
The effect of dietary salt was also assessed on the hypothalamic expression of ENaC 
subunits, VP, OT, and MR in SD rats (See Fig. 3.2). No difference was observed in the 
hypothalamic ENaC subunit expression between dietary treatments. Hypothalamic MR 
expression, however, was significantly lower in SD rats fed a high salt diet compared to those 
fed the control diet (p=0.048). Expression of VP and OT was significantly higher in SD rats fed 
high salt diet (p=0.047 and p=0.024, respectively). Additionally, ENaC expression in the kidney 
was examined (Fig. 3.2B), and SD rats fed a high salt diet had significantly lower αENaC 
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expression compared to those fed the control diet (p=0.005). There was no detectable difference 
in the kidney β- and γENaC expressions between dietary treatments.  
 
 
Fig. 3.1. Dietary salt intake increases hypothalamic γENaC, VP, and OT expression in Dahl-SS. 
A. Dahl-SS rats fed high salt diet for 21 days had significantly higher γENaC, VP, and OT 
mRNA expression in the hypothalamus compared to animals fed control diet, whereas MR, α- 
and βENaC hypothalamic mRNA expression was not affected by dietary treatment. B. No 
significant difference was detected in ENaC mRNA expression in the kidney between animals 
fed high salt diet or control. 
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Fig. 3.2. SD rats fed high dietary salt had decreased MR in the hypothalamus and αENaC 
expressions in the kidney. A. No significant difference was detected in hypothalamic ENaC 
subunit expression between treatment groups; however, SD rats fed high salt diet had 
significantly lower MR mRNA expression and significantly higher VP and OT mRNA 
expression compared to animals fed control diet. B. Expression of αENaC mRNA in the kidney 
was significantly lower in animals fed high salt diet compared to those fed control diet; however, 
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Dahl-SS rats have increased hypothalamic γENaC abundance and proteolytic 
cleavage   
 
Proteins were extracted from the hypothalamus of SD and Dahl-SS rats fed control or 
high salt diet for 21 days. The effect of dietary salt intake on the ENaC subunits abundance was 
assessed by semi-quantitative immunoblotting (Fig. 3.3). From the protein extract, a distinct 
band was detected at the predicted molecular weight of 87 kDa and 85 kDa by the αENaC and 
γENaC antibodies, respectively (Fig. 3.3A). A smaller, second band with a molecular weight of 
70 kDa was detected by the γENaC antibody in Dahl-SS rats fed the high salt diet. There was no 
band detected by the βENaC antibody in the protein extract from the hypothalamus. Normalized 
optical density (OD) measurements were compared between strains and showed that Dahl-SS 
rats that were fed the control diet had a significantly higher abundance of the γENaC subunit 
(113.7± 6.8 OD) compared to SD rats fed the control (91.79± 3 OD; p=0.017) or high salt 
(86.66± 8.24 OD; p=0.007) diets. There was no difference in αENaC abundance between strains 
or diet (Fig. 3.3B).  
Dahl-SS rats fed high salt diet have significantly higher plasma osmolality  
 In addition to tissue collection, plasma samples were collected from rats fed a high salt or 
a control diet for 21 days (Fig. 3.4). Dahl-SS rats fed the high salt diet exhibited a significantly 
higher plasma osmolality compared to those fed the control diet (p<0.001). SD rats showed no 
difference between dietary treatments. There was no difference detected in the plasma osmolality 
of Dahl and SD rats fed control diet. Further experiments were conducted to determine if there 
was a strain specific effect over time that could offer further explanation for discrepancies with 
our previous study using SD rats fed high salt diet for 7-10 days and demonstrated changes in 





Fig. 3.3. Dahl- SS rats have increased γENaC abundance and dietary salt intake promotes 
proteolytic cleavage of γENaC. A.  Immunoblots showing the abundance and molecular weights 
of ENaC subunits in SD and Dahl-SS rats fed high salt or control diet for 21 days. For each blot, 
each lane is representative of an individual animal and loaded with protein extract from the 
hypothalamus. Antibodies detected a single band for αENaC and γENaC at approximately 87 
kDa and 85 kDa, respectively, in SD rats fed control or high salt diet and Dahl-SS rats fed 
control diet. Dahl-SS rats fed high salt diet displayed a second, smaller band for γENaC at 
approximately 70 kDa. No band was detected for βENaC for the extract regardless of strain or 
diet treatment. B. Densometric measurements for each band of the αENaC immunoblot detected 
no difference between strains or dietary treatments; however, densometric measurements for 
each band of the γENaC immunoblot demonstrated significantly higher abundance in Dahl-SS 
rats fed control diet compared to SD rats fed control diet (*p=0.017) and Dahl-SS rats fed high 



































Fig.3.4. Dahl-SS rats fed high salt diet for 21 days had increased plasma osmolality. SD rats fed 
high salt diet for 21 days had no significant difference in plasma osmolality compared to animals 
fed control diet, whereas Dahl-SS fed high salt diet had significantly higher plasma osmolality 
compared to those fed control diet.  
 
Dahl-SS rats fed high salt diet have a prolonged increase in plasma osmolality  
To further examine the plasma osmolality difference observed, a time course collection 
of plasma osmolality was completed in SD and Dahl-SS rats fed the high salt diet for 22 days 
(Fig. 3.4.5). Plasma samples were collected for 7 days prior to starting the high salt diet to 
establish a baseline osmolality for each group, which showed no difference between strains. 
Within two days of starting the high salt diet, both strains had an increase in plasma osmolality. 
SD rats had an increase in plasma osmolality until day 8 and then had a steady decrease to 
baseline measurements by day 19. Dahl-SS rats had a prolonged increase in plasma osmolality 
and plateaued at the peak after 15 days on the high salt diet. These results demonstrate a strain 
difference effect that occurs over time and suggest SD rats exhibit a compensatory mechanism to 






















Fig 3.5. Dahl-SS rats fed high salt diet had a prolonged increase in plasma osmolality. SD rats 
that consumed high salt diet for 23 days had an initial increase in plasma osmolality that peaked 
at day 8 and then gradually returned to baseline measurements by day 21. Dahl-SS rats had a 
prolonged increase in plasma osmolality that peaked and plateaued at day 15. Experiments 
performed by: K.Sharma 
 
Dahl-SS rats have increased somato-dendritic γENaC immunoreactivity in the SON  
Immunoreactivity of the γENaC subunit was examined in the SON of SD and Dahl-SS 
fed a control or a high salt diet (Fig. 3.6). Localization of γENaC immunoreactivity among all 
the animals examined was consistent and found exclusively in MNCs in the SON (Fig. 3.4.6A). 
Dahl-SS rats fed the control diet had significantly more dense-immunoreactive cells in the SON 
(46.67± 21.7) compared to SD rats (1±1) that were fed the control diet (p=0.019; Fig. 3.4.6B).  
The total legnth of the immunoreactivy dendritic processes had a tendency to increase in length 
in Dahl-SS rats fed high salt diet, but this was not found to be a significant difference due to the 
low n- value used for this experiment.  
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Fig 3.6. Dahl-SS rats have increased somato-dendritic γENaC immunoreactivity in the SON A. 
Photomicrographs shown are representative of an animal for each strain and diet treatment. 
Immunoreactivity to γENaC was found exclusively in the MNCs of the SON in both SD and 
Dahl-SS rats regardless of dietary treatments; however, Dahl-SS rats displayed dense cellular 
immunoreactivity (arrows) as well as immunoreactive processes (arrowheads), which were not 
observed in SD rats. B. The number of dense immunoreactive cells was significantly higher in 
Dahl-SS rats compared to SD rats fed control diet; however, no difference was observed between 
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Intra-strain analysis found no difference in the number of dense-immunoreactive cells between 
dietary treatments. In addition to differences in immunoreactivity, Dahl-SS rats had γENaC 
immunoreactive processes present (Fig. 3.6A). SD rats had no immunoreactive processes 
detected in either dietary treatment. The total number of γENaC immunoreactive cells in the 
SON was not affected by dietary treatment or strain type.  
Discussion 
 The present study demonstrated that the expression and abundance of ENaC within the 
hypothalamus is influenced by dietary salt in Dahl-SS rats. Specifically, Dahl-SS rats fed high 
salt diet had increased γENaC expression in the hypothalamus, whereas the αENaC and βENaC 
subunit expressions remained at basal levels. Regardless of diet treatment, Dahl-SS rats have 
higher γENaC abundance in the hypothalamus compared to normotensive SD rats. In the 
hypothalamic tissue examined, γENaC immunoreactivity was located prominently in the VP 
MNCs of the SON and PVN (Teruyama et al., 2012), suggesting that changes in γENaC 
expression in response to dietary salt intake occurred specifically in VP neurons.     
It was previously shown in Dahl-SS rats that aldosterone is synthesized in the 
hypothalamus (MacKenzie et al., 2000; Gomez-Sanchez & Gomez-Sanchez, 2003; Gomez-
Sanchez et al., 2005) and contributes to the development of salt-dependent hypertension in Dahl-
SS rats (Huang et al., 2009; Gomez-Sanchez et al., 2010). Central aldosterone synthesis is higher 
in Dahl-SS rats compared to SD rats and inhibition of aldosterone synthase attenuated the salt 
induced hypertension in Dahl-SS (Gomez-Sanchez et al., 2010). Additionally, both aldosterone 
synthase (Wang et al., 2016) and 11β–hydroxysteriod dehydrogenase type 2 (11β-HSD2), an 
enzyme that promotes aldosterone binding to MR (Funder, 1995; Naray-Fejes-Toth et al., 1998), 
are expressed in MNCs in the SON (Haque et al., 2015). This suggests the increased γENaC 
	 87	
expression observed in Dahl-SS rats fed a high salt diet is a result of central aldosterone binding 
to MR in VP neurons. In contrast, SD rats fed a high salt diet for 21 days resulted in a decreased 
hypothalamic MR expression and no changes in hypothalamic ENaC expression. A previous 
study demonstrated that inbred Dahl-salt resistant rats fed high salt diet had decreased 
hypothalamic aldosterone levels independent from plasma aldosterone, suggesting an inhibitory 
mechanism that decreased central aldosterone synthesis (Huang et al., 2009). These results 
suggest that a high salt diet initiates a central pathway involving aldosterone-MR-ENaC in salt-
sensitive animals to increase VP neuronal activity and contribute to hypertension development.  
 Although full activity of ENaC requires all three subunits, changes in specific ENaC 
subunit expression affects channel activity. Studies completed in cultured collecting duct cells 
and human lung adenocarcinoma cells showed that selectively increasing γENaC expression by 
an adenovirus system resulted in a three-fold increase in Na+ transport (Volk et al., 2005; Husted 
et al., 2007) and a longer channel half-life (Volk et al., 2005). It was demonstrated in Xenopus 
laevis oocytes that the γENaC subunit has specific domains that are important in increasing 
channel surface expression and function (Konstas & Korbmacher, 2003). These findings, in 
addition to our previous study examining the effects of dietary salt in SD rats (Sharma et al., 
2017), suggest that ENaC activity could be increased in VP neurons of Dahl-SS rats fed high salt 
diet.  
Additionally, our current study examined hypothalamic ENaC protein abundance in SD 
and Dahl-SS rats. Regardless of diet treatment, Dahl-SS rats had a higher hypothalamic γENaC 
abundance compared to SD rats. Dahl-SS rats fed a high salt diet resulted in a shift in the 
molecular weight of the γENaC from 85 to 70 kDa. The proteolytic processing of ENaC is 
important for the regulation of ENaC activity (Rossier, 2004; Kleyman et al., 2006). The 
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proteolytic cleavage of the γENaC subunit releases an extracellular inhibitory domain (Passero et 
al., 2010), which is necessary for full channel activation (Berman et al., 2015; Shobair et al., 
2016) and enhanced activity (Hughey et al., 2004). This shift in molecular weight was 
documented in the kidney collecting tubule during salt deprivation to prevent sodium loss 
(Masilamani et al., 1999). The proteolytic form of the γENaC subunit in the hypothalamus of the 
Dahl-SS rats fed a high salt diet indicates enhanced ENaC activity in VP neurons in response to 
physiological demands associated with increased dietary salt intake.   
Plasma aldosterone is an important regulator of ENaC activity within epithelia, and 
circulating levels are usually inversely correlated with dietary salt intake (Oki et al., 2012; 
Funder, 2017). During the time of sodium restriction plasma aldosterone levels are elevated and 
result in increased αENaC expression in the kidney distal tubule to prevent sodium waste (Asher 
et al., 1996; Escoubet et al., 1997; Stokes & Sigmund, 1998; Masilamani et al., 1999; Sharma et 
al., 2017). Conversely, during salt loading, plasma aldosterone levels decrease (Oki et al., 2012; 
Funder, 2017). Our present study shows that SD rats fed a high salt diet have decreased kidney 
αENaC expression compared to SD rats fed the control diet, which may be caused by low plasma 
aldosterone levels to promote sodium excretion in the urine. In addition to the decreased 
hypothalamic MR expression, decreased kidney αENaC during high salt diet intake may be part 
of a compensatory mechanism to maintain sodium homeostasis and prevent development of salt-
induced hypertension. This is further supported by the plasma osmolality measurements that 
showed SD rats had an initial rise is plasma osmolality during high salt consumption, which 
peaked on day 8 and then returned to levels comparable with baseline measurements.  
 Dendrites of MNCs contain peptide synthesis components to translate peptides that may 
be needed locally in response to extracellular stimuli and increased neuronal activity, as well as 
	 89	
secretory components for vesicle exocytosis (Morris et al., 2000). Collected SON tissue from 
Dahl-SS rats had dense γENaC immunoreactivity in cell bodies and dendrites. As demonstrated 
in our previous study, dietary salt intake increased γENaC expression and associated enhanced 
ENaC activity in VP neurons (Sharma et al., 2017). It is possible that the observed dendritic 
γENaC immunoreactivity in Dahl-SS rats contributes to an enhanced VP neuronal activity, 
which may be involved in the etiology of the development of salt-sensitive hypertension. Further 
studies need to be conducted to determine if Dahl-SS rats have increased basal ENaC activity 
compared to normotensive rats. Additionally, ENaC activity should be assessed in Dahl-SS rats 
fed a high salt diet.   
 The findings from this study suggest that hypothalamic ENaC expression, specifically the 
γENaC subunit, is involved in the etiology of salt-sensitive hypertension development in Dahl-
SS rats. Given the role ENaC has in the resting membrane potential of VP neurons (Teruyama et 
al., 2012; Sharma et al., 2017) and the enhanced ENaC activity in these neurons during high 
dietary salt consumption (Sharma et al., 2017), it is possible that VP neurons exhibit enhanced 
neuronal activity and subsequent hormone release that have large systemic effects.   
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CHARACTERIZATION OF THE 4B HYPOTHALAMIC CELL LINE AS A 





Epithelial sodium channel (ENaC) expression and function is regulated by a number of 
hormones and signal transductions mechanisms that are dependent upon the tissue type, subunits 
expressions, and secondary mediators present. Insulin has been demonstrated to stimulate Na+ 
reabsorption in different portions of the kidney, such as the distal collecting ducts (DeFronzo et 
al., 1976; Feraille et al., 1995), thick ascending limbs (Veelken et al., 1988; Mandon et al., 1993; 
Ito et al., 1997), and proximal tubule (Baum, 1987; Feraille et al., 1992; Feraille et al., 1994). 
Insulin stimulates ENaC through secondary mediators (Mansley et al., 2016), which increase 
channel open probability (Marunaka et al., 1992) and channel density at the cell membrane 
(Blazer-Yost et al., 1998). Within the epithelia, ENaC expression is primarily regulated by the 
main mineralocorticoid, aldosterone, binding to the mineralocorticoid receptor (MR) in a tissue 
specific manner (Renard et al., 1995; Escoubet et al., 1997; Stokes & Sigmund, 1998; 
Masilamani et al., 1999; MacDonald et al., 2000). Studies have also demonstrated that insulin 
and aldosterone have synergistic anti-natriuretic effects (Miller & Bogdonoff, 1954; Fidelman & 
Watlington, 1984; Johnson et al., 1986) through regulation of ENaC mediated Na+ transport 
(Wang et al., 2001). 
Given the limited expression of ENaC within the brain, such as the hypothalamus, (Amin 
et al., 2005), detecting changes in expression and determining potential steps in a regulatory 
pathway can be difficult. In order to further examine ENaC regulation in VP neurons, our lab 
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obtained the immortalized 4B hypothalamic cell line from the lab of Dr. T. Cunningham (North 
Texas Health Science Center). Although using immortalized cell cultures to does not offer an 
exact representation of in vivo neuronal properties, it does offer an alternative means to examine 
signaling pathways of interest. Primary cell cultures contain a heterogeneous mixture of cells, 
which may make interpreting signal transductions mechanisms difficult. Additionally, the large 
amount hypothalamic tissue is required to conduct experiments with primary cultures, would be 
costly and require a large number of animals to be sacrificed for each culture.   
The purpose of this study was to determine whether known ENaC regulators, such as 
insulin and aldosterone, could induce ENaC activity and expression in the 4B hypothalamic cell 
line. Over a decade ago the 4B hypothalamic line was generated by immortalizing embryonic 
day 19 rat pup hypothalami using a retrovirus-mediated transfer of the SV40 large T-antigen 
(Kasckow et al., 2003). 4B cells exhibit a neuronal phenotype and express vasopressin and 
corticotrophin releasing factor (CRF) (Kasckow et al., 2003). These cells have been used to 
examine CRF and vasopressin gene regulation (Liu et al., 2006; Kageyama et al., 2007; 
Kageyama et al., 2014). Additionally, 4B cells express functional glucocorticoid receptor and 
CRF type-1 receptors (Kasckow et al., 2003). To test the effects of insulin on ENaC, we 
conducted whole-cell electrophysiology and calcium imaging studies in 4B hypothalamic cells 
and acutely dissociated vasopressin neurons. Changes in ENaC expression was examined in 





Rat hypothalamic 4B cells (obtained from the laboratory of Dr. T. Cunningham, Texas 
Health Science Center) were plated at a density of approximately 5 x 105 in 150-mm Nunc 
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culture dishes (Sigma-Aldrich) and grown to confluence then replated in 35 mm Nunc dishes two 
days prior to electrophysiology or imaging experiments. Cells were grown in Dulbecco’s 
Modified Eagle’s Medium/ Nutrient Mixture F12 Ham’s Liquid media supplemented with 10% 
newborn calf serum (Gemini Bio-Products), 1% MEM nonessential amino acids, 1% Glutamax, 
1% sodium pyruvate, and 1% Pen-Strep. Cells were serum deprived overnight prior to all 
experiments.  
Reagents and solutions 
All components were purchased from Sigma-Aldrich (St Louis, MO) unless otherwise 
stated. The external solution used for calcium imaging and electrophysiology was a modified 
artificial cerebral spinal fluid (aCSF) with the following components (in mM): NaCl (143.25), 
KCl (2.5), CaCl2 (2), D-glucose (20), HEPES (10), and ascorbic acid (0.4). For experiments 
examining effects of high K+, all components remained the same with the exception of KCl (100) 
and NaCl (43.25). Internal pipette solution consisted of (in mM): K-gluconate (135), NaCl (10), 
HEPES (10), phosphocreatine (10) EGTA (0.1), GTP(Na+) (0.4), and ATP(Mg2+) (2) with a final 
pH of 7.31 and 305 mOsmol/L osmolality. Insulin was added to modified aCSF with a final 
concentration of 100 nM.  
Electrophysiology  
Whole- cell voltage clamp recordings were performed using Axopatch 1D amplifier, 
Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular Devices, Sunnyvale, CA). 
Patch pipette electrodes with a tip resistance between 5-10 MΩ were pulled from thick-walled 
borosilicate glass (1.5 mm O.D., 0.86 I.D.) using a P-97 Flamin/Brown Puller (Sutter 
Instruments, Novato, CA). A reference Ag/AgCl electrode pellet was placed in 3 M KCl and 
connected to the culture dish with a 3 M KCl agarose bridge. All recordings were performed at 
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room temperature and a pressurized perfusion system (AutoMate Sceintific, Berkeley, CA) was 
used to deliver external solutions. Cells were grown to approximately 20-30% confluency on a 
35 mm Nunc plate. 
Immunocytochemistry 
Cells were plated at a density of 5 x 10^4 on 18-mm/sq coverslips coated with poly-D-
lysine (Sigma-Aldrich). Cells were serum deprived overnight before fixation. The morning of the 
experiment, cells were rinsed with sodium phosphate buffered saline (PBS; pH 7.2) and the 
media was replaced with 4% paraformaldehyde in PBS for the 30 min to fix the cells at room 
temperature. Coverslips were then washed three times with PBS followed by a 1 hr incubation 
with 5% normal goat serum in PBS-1% Triton (PBST). Primary antibodies were diluted in PBS 
and coverslips were incubated overnight at 4 degrees C. The next day, coverslips were incubated 
with the secondary antibody (goat anti-rabbit) conjugated with DyLight 594 (Jackson 
ImmunoResearch, West Grove, PA) for 2 hrs at room temperature. The coverslips were washed 
three times with PBS and mounted on glass slides using mounting media (Vector Laboratories, 
Burlingame, Ca) containing the fluorescent nuclear stain 4’6-diamindino-2-phenlylindole 
(DAPI). Images were acquired using a Leica DFCC7000 T Camera (Leica DM6 B Upright 
Microscope; Leica Microsystems, Buffalo Grove, IL).  
Western blot 
 Total protein lysate samples were collected from the plated cells. Cells were rinsed with 
cold phosphate buffer solution and placed in microcentrifuge tubes containing 250 µl of chilled 
complete lysis buffer that was made fresh before each experiment. Complete buffer contained: 
RIPA buffer (50 mM NaCl, 1.0% IGEPAL® CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 50 
mM Tris, pH 8.0; Sigma-Aldrich), protease inhibitors (ProteoGuardTM EDTA-free protease 
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inhibitor cocktail; Takara Clontech), 1 mM EGTA, 1 mM EDTA, and 1mM DTT (Sigma-
Aldrich, St. Louis, MO). Samples were briefly homogenized with an electric tissue lyser 
(Qiagen, Valencia, CA) and allowed to stand on ice for 10 min. Lysed samples were centrifuged 
for 20 min at 12,000 rpm at 4°C. The pellet was discarded and the supernatant (total lysate) was 
transferred to a clean tube to be stored at -20°C for later processing.  
 The protein concentration was determined (BCA kit; Pierce Chemical Co., Rockford, 
Illinois, USA); samples (15-20 µg of protein) were denatured by heating in 1x Laemmli buffer 
(Bio-Rad, Hercules, CA) for 5 min at 95 °C. Samples were resolved in a 4-15% SDS-PAGE 
(Mini PROTEAN Precast Gels, Bio-Rad, Hercules, CA) gradient gel in Tris-glycine buffer (25 
mM, 192 mM glycine, 0.1% SDS, pH 8.3; Bio-Rad) and transferred to a PVDF membrane (Bio-
Rad, Hercules, CA) under wet conditions (50V for 2 hr at 4°C). To determine a successful 
transfer, the membrane was stained with Ponceau S solution (Sigma-Aldrich, St. Louis, MO) for 
approximately 1 min. The membrane was destained with 0.1 M NaOH for 30 sec followed by a 1 
min TBST (Tris-GlycineTween; 50 mM Tris base, 200 mM NaCl, 0.05% Tween 20) wash. The 
membrane was treated with 5% non-fat milk buffer (NFM; Bio-Rad) for 1 hr at room temp. The 
membrane was incubated overnight at 4 °C with the selected primary antibody dissolved in 5% 
NFM buffer. A final concentration for all primary antibodies was 1 µg/ml. The membrane was 
washed three times for 10 min each with TBST and incubated with Goat- anti Rabbit horseradish 
conjugated secondary antibody (1:10,000; Bio-Rad) dissolved in 5% NFM buffer at room temp 
for 2 hr followed by six TBST washes for 10 min each. Protein bands were detected through 
chemiluminscence reagents (ClarityTM Western ECl Substrate Kit; Bio-Rad) and imaged using a 




Calcium imaging  
 
The fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1 AM (OGB; 2 uM, Life 
Technologies) was prepared as a 2 mM stock in DMSO. OGB stock and Pluronic F-127 (2.5% 
wt/vol in DMSO, Life Technologies) were mixed in a 1:1 ratio and sonicated for 30 sec. OGB 
and Pluronic mixture (2 uL) was added to 1 mL of HBSS and briefly vortexed followed by 
sonication for 30s. Cells were then incubated with mixture for 1 hr at room temperature in dark 
conditions. Following incubation, cells were rinsed with modified aCSF. Sample collection rate 
was set for 2 sec intervals with an exposure time of approximately 150 ms. Images were captured 
on an inverted Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke, 
Kelheim, Germany). Data were collected and analyzed using Slidebook software (Intelligent 
Imaging Innovation, Denver, CO). In all calcium imaging experiments, the deltaF/F value was 
collected for each treatment. A repeated measures one-way ANOVA to was used for comparison 
between treatment groups with a Tukey post-hoc analysis. Differences were considered to be 
statistically significant at p< 0.05.  
Results 
 
4B hypothalamic cells do not express all ENaC subunits 
Preliminary qRT-PCR results indicated that all ENaC subunits and the MR were 
expressed in the 4B hypothalamic cell line. Western blot and ICC studies were conducted to 
determine if ENaC peptides were also expressed in the cells. Results indicate that the αENaC 
subunit peptide was not expressed in this cell line (Fig. 4.1). Our past studies demonstrated that 
aldosterone induced ENaC subunit expression and abundance in vasopressin neurons. Initial 
experiments were conducted examining aldosterone incubation, but not enough replicates were 
collected to account for experimental errors. After incubation with aldosterone or vehicle, qRT-
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PCR methods were used and the ENaC subunits were no longer detectable. It is possible cells 
were not serum deprived long enough and serum growth factors affected the RNA extraction 




Fig. 4.1: 4B hypothalamic cells line does not express the αENaC subunit peptide. A. 
Deconvolution image showing the neuronal morphology of the 4B cell line (top right). 
Immunocytochemistry staining for all three ENaC subunits showed weak immunoreactivity for 
the αENaC subunit and robust staining for the β- and γENaC subunits. B. Completed Western 
blots did not detect the αENaC peptide at the appropriate molecular weight (indicated by the red 








Insulin exposure induces an inward current and increased intracellular Ca2+ in 4B 
hypothalamic cells 
 
To examine the electrical properties of the 4B hypothalamic cell line, whole cell patch 
voltage clamp experiments were conducted to examine if a ENaC- mediated current was present. 
Preliminary studies showed no current change in hypothalamic 4B cells when held at -70 mV 
exposed to benzamil, an selective ENaC blocker. Because insulin is a known activator in distal 
collecting duct cells, I asked whether insulin exposure would induce an inward, ENaC-mediated 
current. In an attempt to induce a detectable current, cells were exposed to 100 nM insulin for 30 
seconds while being held at -70 mV (Fig. 4.2). Insulin exposure resulted in an initial small 
outward current (denoted by red asterisks) that was quickly followed by a large inward current 
(indicated by black arrows) (Fig. 4.2A). Experiments were conducted to block the insulin- 
induced current by benzamil. However, no useable data was collected from these initial studies, 
as we were not able to reproducibly produce the insulin-induced current. Further experiments 
will need to be conducted to confirm the insulin-induced current is reproducible.  
 Calcium imaging studies showed that 4B hypothalamic cells exposed to insulin for 30 
seconds resulted in a significant increase in intracellular calcium levels (RM ANOVA, p=0.0176; 
Fig. 4.2B). Preliminary experiments were conducted to identify the source of the increased 
intracellular calcium by using calcium free external media (RM ANOVA, p<0.0001; Fig. 4.2C). 
Cells exposed to insulin had a significant increase in intracellular calcium (1± 0.00017) 
compared to control levels (0.99877± 0.000163). Mean control values were calculated by 
averaging the last ten time points before switching solutions. The cells were then washed with 
calcium-free media and exposed to insulin. There was a significant decrease in intracellular 
calcium levels from the calcium-free control (0.993± 0.00023) when exposed to insulin (0.9987± 
0.00026). The cells were then washed in normal media and exposed to insulin, which caused a 
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slight increase in intracellular calcium. To better demonstrate the effects of insulin on 
intracellular calcium elevations in 4B hypothalamic cells, an example trace of raw fluorescent 






Fig. 4.2: Insulin induces inward currents and increases intracellular calcium in 4B hypothalamic 
cells. A. Whole cell voltage recordings were conducted in 4B cells and held at -70 mV. Cells 
were exposed to 100 nM insulin for 30 seconds, which resulted in an initial outward current (red 
asterisks) followed by a large inward current (black arrows). B. Insulin exposure resulted in 
elevations in intracellular calcium (n=26). C. Insulin-induced intracellular calcium elevations is 




   
Fig. 4.3. Raw calcium imaging fluorescent intensities demonstrating effects of insulin in 4B 
hypothalamic cells. A representation of raw data measuring exposure of insulin, which resulted 
in large intracellular calcium elevations. Insulin exposure is indicated by a red bar.  
 
  
High K+ solution results in an increase in intracellular Ca2+ in 4B hypothalamic cells 
 
To determine if the 4B hypothalamic cell line expressed voltage gated Ca2+ channels, 
cells were exposed to high K+ solution to depolarize the membrane to -20 mV (Fig. 4.4). Cells 
exposed to high K+ solution for 10 seconds had a significant increase in intracellular calcium 
(1.006 ± 0.0013) compared to control measurements (0.9966 ± 0.0011) (Fig. 4.4A). After 
removing the high K+ solution, intracellular calcium levels returned to levels comparable with 
the control (0.9968 ± 0.0017). Mean control values were calculated by averaging the last ten time 
points before switching solutions. These findings indicate that the 4B cell line has voltage 
sensitive calcium channels. Experiments were then conducted using calcium channel blockers to 
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confirm the role of calcium channels in the detected response. Lanthanum chloride (LaCl3), a 
non-specific calcium channel blocker, was used to elucidate the source of the observed increase 
in intracellular calcium during membrane depolarization (RM ANOVA p<0.0001, Fig. 4.4B; see 
table for post-hoc values;). Data collected showed no difference in intracellular calcium levels 
when the cells were first washed with LaCl3 and then exposed to high K+ + LaCl3 solution, 
suggesting external calcium was needed for the observed voltage dependent calcium elevation. 
However, once exposed to LaCl3 cells no longer exhibited a response to high K+ solution despite 
an extended wash step with normal media for 1 minute. The role of voltage gated calcium 
channels was investigated using a selective L-type calcium channel blocker, nifedipine (RM 
ANOVA p<0.0001, Fig. 4.4C; see table for post-hoc values). Cells exposed to high K+ solution 
showed a significant increase in intracellular calcium (1.002 ± 0.0003) compared to control 
measurements (0.9989 ± 0.0001; p<0.0001). After washing the cells with normal media for 1 
minute, the cells were then exposed to nifedipine for 30 seconds and the high K+  + nifedipine 
solution for 10 seconds. Interestingly, nifedipine and high K+ solution (1.0012 ± 0.0005) caused 
a significant decrease in intracellular calcium levels compared to the nifedipine control 
measurements (1.0015 ± 0.005; p=0.0315) suggesting that L-type calcium channels are involved 
in the observed calcium elevation. After washing the cells with normal medium for 1 minute, 
high K+ solution was applied for a second time in an attempt to recover the initial calcium 
elevation. However, the second high K+ solution application did not increase intracellular 
calcium (1.0004 ± 0.0003), but resulted in a significant decrease compared to the second control 
measurement (1.0014 ± 0.00029; p=0.0001).  To better demonstrate the effects of insulin on 
intracellular calcium elevations in 4B hypothalamic cells, an example trace of raw fluorescent 
intensities is shown (Fig. 4.5).  
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Fig. 4.4. High K+ solution induces intracellular calcium elevations in 4B hypothalamic cells. A. 
Exposure to high K+ solution for 10 seconds depolarized 4B cells to -20 mV and induced 
intracellular calcium elevation (n=29). B. LaCl3 exposure prevented intracellular calcium 
elevations in 4B cells when exposed to high K+ solution (n=71). C. 4B cells were initially 
exposed to high K+ solution resulted in a significant increase in intracellular calcium 
(*p<0.0001), whereas nifedipine and high K+ solution resulted in a decrease in intracellular 
calcium (**p=0.0315). A second exposure to high K+ solution resulted in a further decrease in 
intracellular calcium levels (***p=0.001)(n=27).  
 
To better demonstrate the effects of insulin on intracellular calcium elevations in 4B 
hypothalamic cells, an example trace of raw fluorescent intensities is shown (Fig. 4.5). This a 
representative trace showing fluorescent traces for 5 4B hypothalamic cells treated with high K+ 
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Fig. 4.5. Raw calcium imaging fluorescent intensities demonstrating effects high K+ solution in 
4B hypothalamic cells. A representation of raw data measuring exposure of high K+ solution, 




  The present study was conducted to characterize the 4B hypothalamic cell line and 
demonstrated that insulin increases in intracellular calcium and induces an inward current. 
Additionally, depolarization with high K+ also increases intracellular calcium, suggesting that 
this cell line exhibits voltage sensitive properties. Findings from this study provide insight into 
the 4B hypothalamic cell line as a possible model for ENaC regulation.   
Although preliminary qRT-PCR data indicated all ENaC subunits and the MR are 
expressed in the 4B hypothalamic cell line, further western blot and ICC results did not detect 
the αENaC protein. Our past studies demonstrated that aldosterone was able to induce ENaC 
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expression and abundance in vasopressin cells (discussed in chapter 2). However, cells incubated 
with aldosterone did not have detectable ENaC expression. This could have been caused by 
technical error or possible contamination of the cells during the incubation. Additionally, lower 
passage number cells should be used to determine if the higher passage number affected mRNA 
present.  
4B hypothalamic cells exposed to insulin for 30 seconds had in inward current and 
increased intracellular calcium. As previously discussed, insulin stimulates ENaC activity and 
experiments were performed to determine if benzamil, an ENaC blocker, was able to block the 
insulin- induced inward current. Unfortunately, no usable data was obtained because the effect of 
insulin could not be reliably reproduced. This is most likely was caused by the passage number 
of the cells used in these studies. It has been demonstrated that cells of a higher passage number 
have changes in morphology, response to stimuli, and protein expression (Siissalo et al., 2007). 
These studies should be repeated in lower passage number cells to ensure consistency in the 
observed effect of insulin. Calcium imaging studies, however, did consistently show that cells 
exposed to insulin resulted in intracellular calcium elevations. To determine the source of the 
increased calcium, cells were exposed to insulin in calcium free media. Interestingly, cells did 
not respond to insulin in calcium free media, suggesting that extracellular calcium is the source 
of the intracellular calcium elevation. A second application of insulin in normal media did 
increase intracellular calcium, but it was not significant. It is possible that cells were not given 
enough time to recover so the wash step should be extended.  
 Exposure to high K+ solution resulted in an increase in intracellular calcium and several 
follow-up experiments were conducted to elucidate the channel type involved in the observed 
calcium elevation. LaCl3 was used as a non-selective calcium blocker to determine the role of 
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calcium channels in intracellular calcium increases. Although the collected results indicate that 
extracellular calcium is required for the calcium elevations, cells exposed to LaCl3 no longer 
exhibited the previously observed voltage response. The overall experimental design could be 
improved upon to further investigate the role of calcium channels. Cells should first be exposed 
to normal media and then high K+ solution to ensure that the cells do exhibit a voltage response. 
Additionally, the one minute wash step after exposure to LaCl3 may need to be extended to 
ensure that the blocker has been completely removed from the cells. Although there was a slight 
increase in the intracellular calcium level when the cells were exposed to high K+ solution after 
LaCl3 exposure was not a significant increase and may be caused by residual LaCl3.  
Nifedipine, a selective L-type calcium channel blocker, was used to examine the role of 
these channels in the observed increased intracellular calcium levels in response to membrane 
depolarization. Results from this study indicate that L-type calcium channels are involved in the 
voltage response in 4B hypothalamic cell line. However, the experimental design should be 
modified to provide more accurate results. The duration of the wash steps after each exposure to 
high K+ and Nifedipine should be extended. The results suggest that the cells were not given an 
adequate amount of time to recover from these exposures. However, results from these 
preliminary experiments are promising and should be investigated further.  
 Using a cell line as a model to investigate signaling pathways and regulatory mechanisms 
has many benefits; however, there are several factors that should be considered when designing 
experiments and interpreting results. The findings from the preliminary studies conducted 
examining the 4B hypothalamic cell line as potential model stresses the importance in 
controlling the passage number of the cells used and potential outside containments. Western 
blot and immunocytochemistry results indicate that functional ENaCs are not expressed in this 
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particular cell line. In order to consider the 4B hypothalamic cell line as a potential model for 
ENaC regulation further studies have to be conducted to induce functional channels before 
continuing to investigate characteristics of the cell line.  
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 Approximately 30% of the American population suffers from salt-sensitivity, which 
causes individuals to have increased risks of morbidity and mortality (Franco & Oparil, 2006). 
Elucidating the mechanism and regulatory pathway involved in salt-sensitive hypertension 
development is necessary to contribute to pharmacological therapies to treat individuals with this 
disease. As there is a growing amount of evidence to suggest that abnormal regulation of central 
ENaC in salt-sensitivity, we sought to examine the regulation of ENaC expression in vasopressin 
neurons in the hypothalamus of normotensive and salt-sensitive animals.   
In the second chapter, we were the first to show that aldosterone binds to the MR to 
regulate specifically the γENaC subunit expression and abundance in vasopressin neurons. 
Additionally, it was demonstrated that the aldosterone-MR complex directly interacts with the 
promoter region of the γENaC gene. Aldosterone, however, did not affect the ENaC-mediated 
current or subcellular distribution. This finding suggests that additional regulatory factors are 
required to influence ENaC trafficking and activity. Corticosterone effects on ENaC expression 
were also examined, and we found increased γENaC expression specifically through binding the 
GR. Together these results provide insights into the regulation of ENaC of expression and 
activity in vasopressin neurons.  
 In the third chapter, the effects of dietary salt on ENaC expression in vasopressin neurons 
and the kidneys in salt-sensitive animals were accessed. Dahl-SS rats, regardless of diet, have 
higher γENaC abundance in the hypothalamus. Additionally, consumption of high dietary salt 
resulted in increased γENaC expression and proteolytic cleavage of the subunit. In contrast, 
normotensive rats fed high dietary salt had decreased MR expression in the hypothalamus and 
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αENaC expression in the kidneys. This is the first time that a potential compensatory mechanism 
has been demonstrated in how normotensive individuals may prevent salt-induced hypertension 
development.  
 In the fourth chapter, the 4B hypothalamic cell line was characterized and investigated as 
a potential model to further investigate ENaC regulation. Preliminary studies from these 
experiments found that functional ENaCs are not expressed in these cells. Interestingly, insulin 
exposure resulted in an inward current and increased intracellular calcium levels. Initial findings 
suggest that this effect is dependent upon extracellular calcium. Additionally, exposing high K+ 
solution to depolarize the cells resulted in increased intracellular calcium. Pharmacological 
studies suggested that this voltage response involves L-type calcium channels. Further studies 
are needed to provide insight into this cell line and its potential use as a model for ENaC 
regulation.  
 As the exact mechanism that mediates central ENaC expression and activity during salt 
sensitive states remains unknown, results from the above mentioned studies provide some insight 
into compensatory mechanisms involving ENaC to counteract hypertension development and the 
hormones potentially responsible for the abnormal ENaC regulation during salt sensitivity. 
Investigation into hormonal regulation of ENaC (Gomez-Sanchez et al., 2005)expression in 
vasopressin neurons revealed two distinct regulatory pathways involving aldosterone and 
corticosterone activating the MR and glucocorticoid receptor, respectively. Studies conducted 
previously in the Teruyama Lab found that magnocellular neurons, including vasopressin-
synthesizing neurons, are considered aldosterone sensitive due to the presence of 11β -HSD2 
(Haque et al., 2015), a glucocorticoid-inactivating enzyme (Gomez-Sanchez et al., 2005). This 
indicates that aldosterone binding to the MR is most likely the primary regulator of ENaC 
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expression in vasopressin neurons. Further experiments using an in vivo approach involving 
animals receiving ICV injections of aldosterone would provide physiological data to supplement 
the transcriptional effect aldosterone has on ENaC expression in vasopressin neurons.  
 The compensatory mechanism observed in normotensive animals fed high dietary salt 
provides insight to the etiology of salt-sensitivity and hypertension development. Additional 
experiments are needed to examine the physiological response salt-sensitive animals have when 
fed high dietary salt. Plasma vasopressin levels should be examined in addition to plasma 
osmolality. As systemic release of vasopressin is directly correlated to the firing activity of the 
synthesizing neuron (Poulain & Wakerley, 1982), plasma vasopressin levels would provide 
insight into the neuronal activity during salt-sensitive states. Electrophysiological studies also 
have to be conducted to examine ENaC activity in vasopressin neurons during salt-sensitive 
states. Our finding that salt- sensitive animals have higher γENaC abundance compared to 
normotensive animals suggest that ENaC activity in vasopressin activity is altered regardless of 
dietary treatment. Given the role the γENaC subunit has in mediating channel surface expression 
and function (Konstas & Korbmacher, 2003), it is likely that salt-sensitive individuals have 
higher basal level ENaC activity. Additionally, electrophysiology experiments have to be 
completed in salt-sensitive animals fed high salt diet to determine if the presence of the 
proteolytic form of the γENaC subunit increases vasopressin neuronal activity. Further 
physiological parameters, such as mean arterial pressure, should be assessed in salt-sensitive 
animals. Using telemetry methods, salt-sensitive animals should exhibit increased mean arterial 
pressure that corresponds to the observed increased plasma osmolality. These experiments are 
necessary to provide a full understanding of how genomic changes in hypothalamic ENaC 
expression has broader, systemic effects.  
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 The mechanism mediating ENaC activity and expression at the level of the kidney is 
complex and involves numerous secondary messengers and hormones (discussed in Chapter 1). 
It is likely that the regulatory component, in addition to the MR and aldosterone, are altered in 
salt-sensitive states. Specifically, expression and activity of 11β-HSD2 should also be assessed.  
It is possible that 11β-HSD2 expression is higher in the SON and PVN in salt-sensitive animals, 
which may contribute to further activation of the MR via aldosterone binding. Interestingly, 
syndrome of apparent mineralocorticoid excess, an autosomal form of salt-sensitivity, is caused 
by a deficiency in 11β-HSD2 at the level of the kidney (Mune et al., 1995; Kotelevtsev et al., 
1999). Although it as not been investigated in the central nervous system, it would provide 
helpful information to investigate the role of 11β-HSD2 in vasopressin neurons during salt-
sensitive states.  
 Hypertension continues to affect a growing number of individuals in industrialized 
countries and is a major risk factor for cardiovascular events and death (Writing Group et al., 
2016). Although the full regulatory mechanism of central ENaC expression remains incomplete, 
findings from our studies provide insight into the abnormal hypothalamic ENaC regulation that 
may contribute to salt-sensitive hypertension development. Further studies should be conducted 
to investigate the involvement of the different regulatory pathways and mechanisms that results 
in an individual being susceptible to salt-sensitive hypertension.   
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